Download William B. Trattler, MD - Center for Excellence in Eye Care

William B. Trattler, MD
The Center for Excellence in Eye Care
8940 North Kendall Drive, Suite 400E
Miami, Florida 33176
(305) 598-2020
[email protected]
NPI # 1093730996
CERTIFICATION
10/98
1/1/2009:
BOARD CERTIFIED IN OPHTHALMOLOGY
Recertified (expires 12/31/2018)
EDUCATION
7/96-7/97
UNIVERSITY OF TEXAS- SOUTHWESTERN MEDICAL SCHOOL, Dallas, Texas
Cornea and External Disease Fellowship
7/93- 7/96
UNIVERSITY OF PENNSYLVANIA/ SCHEIE EYE INSTITUTE
Ophthalmology Residency
7/92-6/93
MOUNT SINAI MEDICAL CENTER, Miami Beach, Florida
Internal Medicine Internship
9/88-5/92
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, Miami, Florida
M.D. Degree with Research Distinction
9/84-6/88
DARTMOUTH COLLEGE, Hanover, New Hampshire
Bachelor of Arts in Biology, cum laude
EMPLOYMENT
7/97-Present
THE CENTER FOR EXCELLENCE IN EYE CARE, Miami, Florida
Private Practice; Subspecialty: Cornea, External Disease, & Refractive Surgery
7/02-7/06
BASCOM PALMER EYE INSTITUTE; Miami, FL (3 half days per month)
Supervised Residents in the Bascom Palmer Eye Emergency Department
Instructed residents in anterior segment surgery (cataract and corneal surgery)
7/97-7/01
V.A. HOSPITAL, Miami, Florida
Surgical Staff: Supervising University of Miami ophthalmology residents in surgery & clinic
ACADEMIC APPOINTMENTS
1/2012-Present
Volunteer in the Department of Ophthalmology, Herbert Wertheim College of Medicine,
Florida International University
7/2000-Present
Volunteer Assistant Professor of Ophthalmology, Bascom Palmer Eye Institute
AWARDS AND HONORS
November 2013
Senior Achievement Award, American Academy of Ophthalmology
Jan 9, 2012
Best Paper of Session, 6th Annual International Military Refractive Surgery Symposium; Jan 2012
1
William B. Trattler, MD
Jan 2012
Best Paper of the Day, Hawaiian Eye 2012 Meeting; Maui, Hawaii; Jan 2012
4/10
PS250: Identified by the publishers and editors of Premier Surgeon as one of the 250 top innovators
in premium IOL implant surgery.
1/10 to present:
Chief Medical Editor, Advanced Ocular Care
website: http://bmctoday.net/advancedocularcare/
4/09 to present:
Medical Editor: Eyetube.net.
4/09
Best Paper of Session; Quantitative Measurement of Accommodation in Phakic Eyes with a Wavefront
Aberrometer; ASCRS 2009
12/07 to 7/2013
Trusted LASIK Surgeons: Qualified and Listed at Trusted LASIK Surgeons, a LASIK directory service
that screens surgeons based on experience, premier patient care, and professional credentials
11/06
Poster 664: Delayed Epithelial Healing With Nepafenac Ophthalmic Solution was “selected as one of the
best posters at the 2006 Meeting of the American Academy of Ophthalmology”, Las Vegas, NV; Nov 13
2006
05/06
Achievement Award; American Academy of Ophthalmology
04/06
Top 50 Cataract & Refractive Surgery Opinion Leaders, as voted on by readers of Cataract & Refractive
Surgery Today.
2006, ‘08-11, ‘13-14 Aspen Invitational Refractive Symposium: Ski Race Champion
2002
Curtis D. Benton, Jr., MD Outstanding Young Ophthalmologist Leadership Award; This award is
presented by the Florida Society of Ophthalmology (FSO) to a Florida ophthalmologist who has
demonstrated leadership, service, competence and devotion to the high ethical and professional standards
of the FSO.
1993-94 & 1995-96
Scheie Eye Institute Teaching Award
1994
Walter Stark, MD Award: “First Place Downhill Racer”, Current Concepts in Ophthalmology meeting,
Vail, Colorado
1991
Alpha Omega Alpha, Medical Honor Society
1989
John H. Fomon Memorial Research Fellowship, American Cancer Society: Support for ocular
immunology research
1987
Raynolds Expedition Fund Grant: Supported shark research in Bimini, Bahamas
RESEARCH POSITIONS/CLINICAL TRIALS
01/11 to 04/11
Insite Vision protocol C-10-303-001: Randomized Double Masked 14 day Study to Compare ISV-303
(0.075% Bromfenac in Durasite) to Vehicle and Xibrom in Post Cataract Surgery Volunteers.
07/10 to present
Corneal Collagen crosslinking with riboflavin for Keratoconus, Pellucid, RK, and Post-LASIK ectasia in
patients as young as 12 years old; Sponsored by CXLUSA
07/10 to present
Multicenter Comparison of Tecnis Multifocal One Piece IOL to Restor D1 Multifocal Intraocular Lens;
Sponsored by Abbott Medical Optics
07/10 to present
Multicenter, Randomized, Masked Comparison of Bromfenac and Besifloxacin BID with Either
Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following
2
William B. Trattler, MD
Phacoemulsification; Unrestricted Grant provided by Bausch and Lomb: Clinicaltrials.gov identifier:
NCT01193504
11/09 to 02/10:
Vistakon CR1649: A Randomized, Double-Masked, Placebo-Controlled Dose-Response Study of the
Safety and Efficacy of Two Dosage Strengths of the Bimatoprost Punctal Plug Delivery System (BPPDS)
Compared to Placebo, Followed by an Open-Label, Single-Dose Bimatoprost 0.03% Ophthalmic
Solution (LUMIGAN®) Challenge; Sponsored by Vistakon
11/09 to 6/10:
RPS ADENO DETECTOR IV™ STUDY PROTOCOL; To compare the sensitivity and specificity of the
RPS Adeno Detector IV™ at detecting the presence of adenovirus to Cell Culture; Sponsored by Rapid
Pathogen Screening (RPS)
11/09 to 02/10:
RPS HSV DETECTOR STUDY PROTOCOL; To compare the sensitivity and specificity of the RPS
HSV Detector at detecting the presence of HSV related keratitis to both cell culture and PCR. Sponsored
by Rapid Pathogen Screening (RPS)
10/09 to 02/10:
Tecnis Multifocal IOL vs Restor Pilot Study: Sponsored by Abbott Medical Optics
10/09 to present
Corneal Collagen crosslinking with riboflavin for Keratoconus, Pellucid, RK, and Post-LASIK ectasia;
Sponsored by CXLUSA; Clinicaltrials.gov identifier: NCT01024322
10/09 to 07/10
Measurement of accommodation with the COAS High Definition Wavefront Aberrometer; Sponsored by
Abbott Medical Optics
06/09 to 07/10
The PHACO Study (Prospective Health Assessment of Cataract Patients’ Ocular Surface); Multicenter
Study, funded by Allergan
06/09 to 10/09
Determine the Presence of Belpharitis in Patients undergoing Cataract Surgery; Multicenter study,
funded by Inspire.
03/09 to 08/09
A Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group Safety and Efficacy
Study of Azithromcyin Ophthalmic Solution, 1% versus Placebo for Four Weeks in Subjects with
Blepharitis (protocol # 044-102): study sponsored by Inspire Pharmaceuticals
02/09 to 10/09:
A three-month, investigator-masked, randomized, multicenter, parallel, clinical trial comparing the
efficacy of Combigan® (fixed combination of 0.2% brimonidine tartrate and 0.5% timolol maleate
ophthalmic solution) versus Xalatan® (latanoprost 0.005% ophthalmic solution) in subjects with ocular
hypertension or open-angle glaucoma. (Study #: GMA-COM-08-008); sponsored by Allergan
2/09 to 7/09
A Multi-Center, Parallel-Group, Double-Masked, Randomized, Placebo-Controlled Study of the Effects
of diquafosol tetrasodium Ophthalmic Solution, 2% in Subjects with Dry Eye Disease and a Central
Corneal Staining Score of 3 (NEI Scale). (protocol # 03-113): study sponsored by Inspire
Pharmaceuticals
2/09 to 5/09
An Open-Label Study To Assess The Efficacy Of A Combination Povidone-Iodine 0,4%
(w/w)/Dexamethasone 0.1% (w/w) Ophthalmic Suspension In The Treatment Of Acute Adenoviral
Conjunctivitis; (OOG-AVC-001); sponsored by Foresight Biotherapeutics
2/09 to 6/09
PPL GLAU 06: A Partially Masked, Phase 2 Study of the Latanoprost Punctal Plug Delivery System (LPPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma (sponsored by QLTI)
1/09 to 10/09:
PPL GLAU 03: An Open-Label, Phase 2 Study of the Latanoprost Punctal Plug Delivery System (L
PPDS) in Subjects With Ocular Hypertension or Open Angle Glaucoma (sponsored by QLTI)
12/08 to 1/09:
A Multicenter, Randomized, Double-Masked, Vehicle-Controlled Pilot Study of the Efficacy and Safety
of Cyclosporine A Ophthalmic Solution (ST-603), 0.1% and 0.2%Compared to Vehicle in Subjects With
Dry Eye Disease; (Protocol # ST-603-010); Sponsored by Sirion
11/08 to 7/2010
Evaluation of outcomes using the AMO advanced Customvue™ iLasik procedure (Wavescan
Wavefront® System, Star S4 IR™ Excimer Laser System and Intralase™ FS System); Sponsored by
AMO-Abbott
11/08 to present
A Device Evaluation Study to Assess the Physical and Clinical Performance of Prototype Punctal Plug
Design Iterations (PP Dev 01); Sponsored by QLTI
3
William B. Trattler, MD
09/08 to 11/08:
Evaluation of the Crystalens HD (Multicenter (5 sites) outcomes (study sponsored by B&L)
7/08 to 1/09:
Evaluation Of The Rezoom™ Multifocal And Crystalens™ Accommodating Intraocular Lenses (AMO )
7/08 to 1/09:
Evaluation Of The Rezoom™ Multifocal And Restor Multifocal Intraocular Lenses (AMO)
7/08 to 11/08
Efficacy and Safety of Xibrom™ (Bromfenac Ophthalmic Solution) 0.09% QD vs. Placebo QD for
Treatment of Ocular Inflammation and Pain Associated with Cataract Surgery; Clinical Trial Protocol:
CL-S&E-0415081-P (Ista)
6/08 to 11/08:
Evaluation Of Artificial Tears (Blink Tears) In Post-Lasik Patients (AMO)
4/08 to 8/09:
Protocol UVX-002: Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking in
Eyes with Progressive Keratoconus
4/08 to 8/09
Protocol UVX-003: Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking in
Eyes with Corneal Ectasia after Refractive Surgery
4/08 to 12/08:
Wavetec: a multi-center, prospective study of the wavetec vision systems aberrometer performed in
subjects undergoing cataract surgery
03/08 to 6/08:
A Multi-Center, Open-Label, Randomized Pilot Study of the Safety and Efficacy of AzaSite®
Ophthalmic Solution, 1% in Combination with Mechanical Therapy versus Mechanical Therapy Alone in
Subjects with Blepharitis (sponsored by Inspire pharmaceuticals); Protocol Number: 041-105
12/07 to 11/08
A Multi-Center, Double-Masked, Randomized, Controlled, Parallel-Group, Three-Month Study (Plus
Three-Month, Masked Extension) to Evaluate the Safety and Efficacy of Twice-Daily Administered
Cyclosporine Ophthalmic Emulsion 0.05% (RESTASIS®) in Accelerating the Recovery of Corneal
Sensitivity in Post-LASIK Patients; PROTOCOL NUMBER: 192371-014-00 (Allergan)
12/07 to 12/07:
SURFACE: Surveillance of Resistance to Formulations of Antimicrobials in Cultures of the Eye
(Allergan)
11/07 to 1/08:
A Multi Center, Double Masked, Randomized Parallel Group Study Evaluating the Safety and Efficacy
of a New Formulation of Ketorolac Tromethamine 0.45% Ophthalmic Solution Compared with Vehicle
Administered Preoperatively and Twice-Daily Postoperatively for Two Weeks for the Treatment of
Anterior Segment Inflammation, Pain, and Inhibition of Surgically Induced Miosis Following Cataract
Extraction with Posterior Chamber Intraocular Lens (IOL) Implantation; Protocol #:191578-006
(Allergan); enrollment complete
11/07 to 1/08:
Efficacy and Safety of Bromfenac Ophthalmic Solution 0.18% QD vs. Xibrom™ (BromfenacOphthalmic
Solution) 0.09% QD for Treatment of Ocular Inflammation, Pain, and Photophobia Associated with
Cataract Surgery; Enrollment Complete
10/07 to 4/08:
A Multi-Center, Double-Masked, Randomized, Two-Arm, Parallel-Group Study to Compare the
Efficacy, Safety and Acceptability of Optive™ Unit-Dose Eye Drops with Refresh Plus® Unit-Dose
Lubricant Eye Drops for Three Months in Subjects following LASIK Refractive Surgery Status:
PROTOCOL NUMBER: AG9818-001-00 (Allergan)
8/07 to 5/08:
A 6 Day, Phase 3, Multicenter, Randomized, Double-Masked, Parallel Study to Compare the Safety and
Efficacy of Gatifloxacin 0.5% Ophthalmic Solution BID with that of Vehicle in the Treatment of Acute
Bacterial Conjunctivitis; PROTOCOL #: 198782-004-00 (Allergan)
8/07 to 4.08:
A Phase 3 Double-Masked, Randomized Study of the Safety and Effectiveness of DYME (Brilliant Blue)
as an Agent for Selective Staining of the Anterior Capsule during Cataract Surgery; Protocol AQNADY001: (Aqumen Biopharmaceuticals N.A., Inc.)
8/07 to 4/08:
“A Multicenter, Masked Evaluation of Ocular Surface Tolerability Associated with Bimatoprost 0.03%,
Travoprost 0.004% (BAK free) or Latanoprost 0.005% Therapy in pts with Glaucoma or OHTN”
7/07 to 9/08:
Phase 3 study: An Open-Label, Safety Evaluation of Cyclosporine A Ophthalmic Solution, 0.1% (ST603) Administered Twice Daily for 12 Months to Subjects With Dry Eye Syndrome (ST-603-006)
6/07 to 11/07:
Phase 3 Study of the Efficacy and Safety of Cyclosporine Ophthalmic Solution, 0.1% (ST-603)
Compared to Vehicle in Subjects With Moderate to Severe Dry Eye Syndrome( ST-603-005)
4
William B. Trattler, MD
6/07 to 4/08:
XPF2 Study: Bromfenac BID Plus Prednisolone Acetate BID versus Bromfenac BID Plus Prednisolone
QID for the Prevention of Cystoid Macular Edema and Retinal Thickening (Principle Investigator)
Carlos; Educational Grant provided by Ista Pharmaceuticals)
3/07 to 11/07:
LenstecTM Softec HDTM Posterior Chamber IOL Clinical Study (Phase 3 study); enrollment complete
3/07 to 8/07:
Phase 3 Multicenter, Randomized, Double-Masked, Placebo-Controlled Study of Difluprednate in the
Treatment of Inflammation Following Ocular Surgery (Sirion Therapeutics study # ST-601A-002a)
11/06 to 1/08:
I-Stent Trabecular Bypass Micro Stent in Combination with Cataract Surgery in Subjects with OpenAngle Glaucoma, GC-003, Glaukos Corporation (Phase 3 study): Enrollment Complete
10/06 to 1/08:
Efficacy of Topical Cyclosporine Ophthalmic Emulsion for the Prevention and Treatment of Dry Eye
Symptoms Following LASIK or Photorefractive Keratectomy: Enrollment Complete
10/06 to 3/07:
VISTAKON® (senofilcon A) Contact Lens Material, A Retrospective Bandage Lens Usage; Review of
the Acuvue Oasys as a Bandage Contact Lens. (Vistakon study CR-1550)
11/06 to 10/07:
LenstecTM TetraFlexTM Accommodating Posterior Chamber IOL Clinical Investigation (IDE
G050048); enrollment complete
1//06 to 04/07:
Evaluation of the IOP-Lowering Effect & Tolerability of Bimatoprost 0.03% (Lumigan®) Compared
with Travoprost 0.004% (Travatan®) in Patients with Glaucoma or OHTN (Allergan MA-LUM01 study)
9/06 to 12/06:
A Randomized Evaluation of Two Surgical Kits: Gatifloxacin, Ketorolac LS, and Pred Forte Compared
with Moxifloxacin, Nepafenac, and EconoPred in Patients Undergoing Cataract Surgery. Complete
8/06 to 9/08:
A Multicenter Study on a Rapid screening tests for detection of HSV in tears; Rapid Pathogens
Screening, Inc
7/06-12/06:
A Randomized, Double-Masked Safety and Efficacy Study of FID #109980 Compared to FID #110656
in the Treatment of Dry Eye; Phase 3 Dry eye study sponsored by Alcon.
7/06-11/06
Comparison of Topical Xibrom™ vs Acular LS for the Control of Pain, Photophobia, and Discomfort
Following PRK; Investigator initiated study, funded by Ista pharmaceuticals
6/06-11/06
Efficacy and Safety of Topical Bromfenac Ophthalmic Solution 0.18% vs. Placebo for Treatment of
Ocular Inflammation & Pain and following Cataract Surgery ISTA-BR-CS02 Protocol; Phase 3 study;
Ista pharmaceuticals; Study completed
6/06-11/06
A multi-center, randomized, double-masked, parallel clinical trial to evaluate the clinical and microbial
efficacy of 0.6% ISV-403 compared to Vigamox in the treatment of bacterial conjunctivitis. Phase 3
study; Bausch & Lomb
5/06-4/07
A Multicenter Evaluation of Methods to Reduce Hyperemia Associated with Bimatoprost Therapy for
Glaucoma or Ocular Hypertension; (Educational Grant provided by Allergan)
5/06-12/06
Comparison of Bimatoprost 0.03% Monotherapy vs. Dual Therapy with Travoprost 0.004% and Timolol
0.5% in Patients with Glaucoma. (Educational Grant provided by Allergan)
5/06-4/07
Brimonidine Purite 0.15% versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost
(Educational Grant provided by Allergan)
2/06-7/06
Comparison of Pred Forte to Acular & Pred Forte for post cataract surgery inflammation (Allergan);
1/06-4/06
Double-masked study of Acular LS vs Nevanac for pain control following PRK (Educational Grant
provided by Allergan);
11/05-3/06
Double-masked study of Acular LS vs Nevanac for pain control following flapless epi-LASIK
(Educational Grant provided by Allergan);
10/5 –3/06
Double-masked comparison of Restasis vs Refresh for Patients with Contact Lens Intolerance
(Educational Grant provided by Allergan);
5/05-6/05
Comparison of Soothe vs Genteal in Patients with Dry Eye due to Computer Vision Syndrome;
(Educational Grant provided by Alimera Sciences)
5
William B. Trattler, MD
4/04 – 8/05
Clinical Investigator for Alcon Pharmaceuticals in their Phase 3 trial on Topical Rimexolone for dry eye
4/04 – 9/04
Clinical Investigator for Inspire Pharmaceuticals in their Phase 3 trial on Diquafosol (for dry eye)
1/04 – 5/04
Comparison of the Speed of Epithelial Healing following LASEK (Educational Grant provided by
Alcon)
3/02-7/02
Clinical investigator for Aqueous Pharma LLC Performed clinical study with TeargardTM for patients
with evaporative dry eye
11/01-2/05
Clinical Investigator of the Medennium/Ciba Vision Phakic Refractive Lens (PRL) Phase 3 Investigation
of Safety and Efficacy for Myopia
6/89-9/89
Summer Research Fellow in Ocular Immunology
Mentors:
Scott Cousins, M.D., Assistant Professor, Bascom Palmer Eye Institute
J. Wayne Streilein, M.D., Professor and Chairman, Department of Microbiology &
Immunology, University of Miami School of Medicine
6/87-9/87
Member of Shark Research Team: Participated in research studying shark growth in Bimini, Bahamas,
and the diet of young lemon sharks near Little Torch Key (in the Florida Keys)
Mentor:
6/85-9/85
Samuel H. Gruber, Ph.D., School of Marine Science, University of Miami
Summer Research Fellow in Ophthalmology
Mentor:
Duco I. Hamasaki, Ph.D., Professor, Bascom Palmer Eye Institute
PUBLICATIONS
Peer-Reviewed Journal Articles indexed in PubMed
1.
Trattler W. December consultation #5.; J Cataract Refract Surg. 2013 Dec;39(12):1935-6. doi:
10.1016/j.jcrs.2013.10.011.
2.
Moshirfar M, Simpson RG, Dave SB, Christiansen SM, Edmonds JN, Culbertson WW, Pascucci SE,
Sher NA, Cano DB, Trattler WB. Sources of medical error in refractive surgery. J Refract Surg. 2013
May;29(5):303-10. doi: 10.3928/1081597X-20130415-01.
3.
Farjo AA, Sugar A, Schallhorn SC, Majmudar PA, Tanzer DJ, Trattler WB, Cason JB, Donaldson KE,
Kymionis GD. Femtosecond lasers for LASIK flap creation: a report by the American Academy of
Ophthalmology. Ophthalmology. 2013 Mar;120(3):e5-e20. doi: 10.1016/j.ophtha.2012.08.013. Epub
2012 Nov 20.
4.
Brown DC, Gills JP 3rd, Trattler WB, Newsom TH, Weinstock RJ, Sanders DR. Prospective multicenter
trial assessing effectiveness, refractive predictability and safety of a new aberration free, bi-aspheric
intraocular lens. Cont Lens Anterior Eye. 2011 Aug;34(4):188-92. doi: 10.1016/j.clae.2011.04.003.
Epub 2011 May 25.
5.
Sher NA, Golben MP, Bond W, Trattler WB. A retrospective review of photorefractive keratectomy to
enhance earlier radial keratotomy. Int Ophthalmol Clin. 2011 Spring;51(2):39-49.
6.
Donnenfeld ED, Nichamin LD, Hardten DR, Raizman MB, Trattler W, Rajpal RK, Alpern LM, Felix C,
Bradford RR, Villanueva L, Hollander DA, Schiffman RM. Twice-Daily, Preservative-Free Ketorolac
0.45% for Treatment of Inflammation and Pain After Cataract Surgery. Am J Ophthalmol. 2010 Dec 8.
[Epub ahead of print]
7.
Olson R, Donnenfeld E, Bucci F, Price F, Raizman M, Solomon K,, Devgan U, Trattler W, Dell S,
Wallace B, Callegan M, Brown H, McDonnell P, Conway T, Schiffman R, Hollander D; Methicillin
resistance of Staphylococcus species among health care and nonhealth care workers undergoing cataract
surgery; Clinical Ophthalmology; December 2010.
6
William B. Trattler, MD
8.
Schechter BA, Trattler W.; Efficacy and safety of bromfenac for the treatment of corneal ulcer pain. Adv
Ther. 2010 Sep 13
9.
Whitson J, Trattler W, Matossian C, Williams J, Hollander D; Ocular Surface Tolerability of
Prostaglandin Analogs in Patients with Glaucoma or Ocular Hypertension; Journal of Ocular
Pharmacology and Therapeutics. June 2010, 26(3): 287-292.
10. Goldman DA, Trattler WB. Cataract surgery and diabetic retinopathy. Ophthalmology. 2010
Apr;117(4):850; author reply 850
11. Binder PS, Trattler WB. Evaluation of a risk factor scoring system for corneal ectasia after LASIK in
eyes with normal topography. J Refract Surg. 2010 Apr;26(4):241-50.
12. Trattler W.; Ocular Surface Disease and Osmoprotection in Refractive Surgery Patients; Highlights of
Ophthalmology. Vol. 38, No 2; 2010
13. Huang D, Schallhorn SC, Sugar A, Farjo AA, Majmudar PA, Trattler WB, Tanzer DJ.; Phakic
intraocular lens implantation for the correction of myopia: a report by the American Academy of
Ophthalmology. Ophthalmology. 2009 Nov;116(11):2244-58. Review.
14. AJ. S. Pelletier · K. Stewart · W. Trattler · D. C. Ritterband · S. Braverman · C. M. Samson · B. Liang ·
J. A. Capriotti; Combination Povidone-Iodine 0.4%/Dexamethasone 0.1% Ophthalmic Suspension in the
Treatment of Adenoviral Conjunctivitis; Adv Ther (2009) 26(8):. DOI 10.1007/s12325-009-0062-1
15. Trattler W, Binder PS; Scoring system minimizes key variables. Ophthalmology. 2009 May;116(5):101
16. Neal A. Sher, MD, FACS; Mikhail P. Golben, BS; William Bond, MD; William B. Trattler, MD;
Shachar Tauber, MD; Terry G. Voirin, DO. Topical Bromfenac 0.09% vs Ketorolac 0.4% for the
Control of Pain, Photophobia, and Discomfort Following PRK. Journal of Refractive Surgery Vol. 25
No. 2 February 2009
17. Buznego C, Trattler WB.; Presbyopia-correcting intraocular lenses. Curr Opin Ophthalmol. 2009
Jan;20(1):13-8.
18. Yuen L, Trattler W, Boxer Wachler BS.; Two cases of Z syndrome with the Crystalens after uneventful
cataract surgery. J Cataract Refract Surg. 2008 Nov;34(11):1986-9.
19. Wittpenn JR, Silverstein S, Heier J, Kenyon KR, Hunkeler JD, Earl M; Acular LS for Cystoid Macular
Edema (ACME) Study Group. A randomized, masked comparison of topical ketorolac 0.4% plus
steroid vs steroid alone in low-risk cataract surgery patients. Am J Ophthalmol. 2008 Oct;146(4):554560.
Collaborators (15): Wittpenn J, Silverstein S, Hunkeler J, Schechter B, Price F, Chu R, Wallace B,
Trattler W, Dougherty P, Goldberg D, Perry H, Solomon K, Donnenfeld E, Kenyon K, Roberts
20. Schallhorn SC, Farjo AA, Huang D, Boxer Wachler BS, Trattler WB, Tanzer DJ, Majmudar PA, Sugar
A; American Academy of Ophthalmology. Wavefront-guided LASIK for the correction of primary
myopia and astigmatism a report by the American Academy of Ophthalmology. Ophthalmology. 2008
Jul;115(7):1249-61.
21. Trattler W, Barnes S; Current Trends in Advanced Surface Ablation; Current Opinion of
Ophthalmology; 2008: 19:330–334
22. Trattler W, Noecker RJ, Earl ML. A multicentre evaluation of the effect of patient education on
acceptance of hyperaemia associated with bimatoprost therapy for glaucoma or ocular hypertension.
Adv Ther. 2008; 2008:25:179-189
23. Randleman JB, Trattler WB, Stulting RD. Validation of the Ectasia Risk Score System for preoperative
laser in situ keratomileusis screening. AJO. 2008 May;145(5):813-8.
24. Krueger RR, Trattler W, Yee R. Introduction to the proceedings of the Sixth International Congress on
Advanced Surface Ablation & SBK. J Refract Surg. 2008 Jan;24(1):S55-6
25. Caster AI, Trattler W. Corneal ectasia after laser vision correction; Int Ophthalmol Clin. 2008
Winter;48(1):73-81.
7
William B. Trattler, MD
26. Trattler WB, McDonald M; Double-Masked Comparison of Ketorolac Tromethamine 0.4% Versus
Nepafenac Sodium 0.1% for Postoperative Healing Rates and Pain Control in Eyes Undergoing Surface
Ablation; Cornea, August 07; 665-669
27. Trattler W, Katsev D, Kerney D; Self-reported compliance with topical cyclosporine emulsion 0.05%
and onset of the effects of increased tear production as assessed through patient surveys.; Clin
Ther.2006 Nov;28(11):1848-56
28. Trattler WB, Luchs J, Majmudar P. Elestat (epinastine HCl ophthalmic solution 0.05%) as a therapeutic
for allergic conjunctivitis. Int Ophthalmol Clin. 2006 Fall;46(4):87-99.
29. Trattler W, Salz JJ. Surface ablation over LASIK flaps. Int Ophthalmol Clin. 2006 Summer;46(3):117-22
30. Salz JJ, Trattler W. Pupil size and corneal laser surgery. Curr Opin Ophthalmol. 2006 Aug; 17(4):373-9.
31. Di Pascuale M, Liu T, Trattler W, Tseng S. Lipid Tear Deficiency in Persistant Dry Eye After Laser in
situ Keratomileusis and Treatment Results of New Eye-Warming Device; JCRS Sep 05; 32 (9)1741-49
32. Durrie D, Trattler W. A Comparison of Therapeutic Regimens Containing Moxifloxacin 0.5%
Ophthalmic Solution and Gatifloxacin 0.3% Ophthalmic Solution for Surgical Prophylaxis in Patients
Undergoing LASIK or LASEK. Journal of Ocular Pharmacology & Therapeutics. 21(3)2005:236-41
33. Trattler W, Whitsett J, Simone, P, Negative Dysphotopsia After Intraocular Lens Implantation
Irrespective of Design & Material, Journal of Cataract and Refractive Surgery. 31 (April 2005): 841-844
34. Salz JJ, Boxer Wachler BS, Holladay JT, Trattler W. Night vision complaints after LASIK
Ophthalmology. 2004 Aug;111(8):1620-1; Comment on: Ophthalmology. 2004 Jan;111(1):3-10.
35. Ta CN, Shine WE, McCulley JP, Pandya A, Trattler W, Norbury JW. Effects of Minocycline on the
Ocular Flora of Patients with Acne rosacea or Seborrheic Blepharitis. Cornea. 2003 Aug;22(6):545-8
36. Cousins S.W., Trattler W.B., and Streilein J.W. Immune Privilege and Suppression of Immunogenic
Inflammation in the Anterior Chamber of the Eye. Current Eye Research. 10 (1991): 287-297.
37. Hamasaki D.I., Trattler W.B., and Hajek A.S. Light ON Depresses and LightOFF Enhances the Release
of Dopamine from the Cat's Retina. Neuroscience Letters. 68 (1986): 112-116.
Abstracts/Posters at National Meetings
1.
Poster #5352 - Evaluation of epi-on corneal collagen cross-linking (CXL) at 6 months and 1 year followup in patients diagnosed with keratoconus and post-LASIK ectasia; European Society of Cataract and
Refractive Surgery (ESCRS); September 2014
2.
Poster # A0248; Loh J, Trattler W, Rubinfeld R, Perez; Evaluation of Transepithelial Corneal Collagen
Cross-Linking (CXL) at 6 months and 1 year Follow Up in Patients with Different Proprietary
Transepithelial Riboflavin Solutions; Presented at The Association for Research in Vision and
Ophthalmology Annual Meeting; May 5th 2014; Orlando, FL
3.
Poster # C0246: Abou-Jaoude M, Trattler W, Buznego C, Hovanesian J, Henderson B; Randomized,
Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol
0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification; Presented at
The Association for Research in Vision and Opthalmology Annual Meeting; May 5th 2014; Orlando, FL
4.
Poster #B0262; Frank B, Trattler W, McCabe S, Correa R, Loh J, Buznego C; The Incidence of
Topographic Abnormalities in Patients Scheduled for Cataract Surgery; Presented at The Association for
Research in Vision and Opthalmology Annual Meeting; May 5th 2014; Orlando, FL
5.
Poster #7036; Trattler W, Frank B, McCabe S, Loh J, Buznego C; Retrospective Review of Incidence of
Abnormal Corneal Topography in Patients Scheduled for Cataract Surgery; Presented at the American
Society of Cataract and Refractive Surgery Annual Meeting; April 25th 2014; Boston, MA
6.
Rubinfeld R, Trattler W, Forstot L, Martin F, Kaiser C, Talamo J, Hatch K, Correa R, Retrospective
evaluation of epithelial –on cross-linking (CXL), Poster Accepted for the American Academy of
Ophthalmology Annual Meeting, November 11, 2012, Chicago, IL
8
William B. Trattler, MD
7.
Trattler W, Buznego C, Luchs J, Adi M, Rubinfeld M, Berdy G, Perez G, Abou-Jaude M, Retrospective
evaluation of patients with a strong response to epithelial –on corneal collagen cross-linking (CXL),
Poster Accepted for the American Academy of Ophthalmology Annual Meeting, November 11, 2012,
Chicago, IL
8.
Trattler W, Lacayo G, Perez G, Feldman S, Majmudar P, Malahotra R, Comparison of epithelial-on
cross-linking for the treatment of mild, moderate, and severe keratoconus, Poster Accepted for the
American Academy of Ophthalmology Annual Meeting, November 11, 2012, Chicago, IL
9.
Rubinfeld R, Trattler W, Forstot L, Martin F, Kaiser C, Talamo J, Hatch K, Correa R, Retrospective
evaluation of epithelial –on cross-linking (CXL), ePoster Accepted for the ISRS subspecialty day
meeting, AAO, November 9-10, 2012, Chicago, IL
10.
Trattler W, Lacayo G, Perez G, Feldman S, Majmudar P, Malahotra R, Comparison of epithelial-on
cross-linking for the treatment of mild, moderate, and severe keratoconus, ePoster Accepted for the ISRS
Subspecialty day Meeting, AAO, November 9-10, 2012, Chicago, IL
11.
Trattler W, Buznego C, Luchs J, Adi M, Rubinfeld M, Berdy G, Perez G, Retrospective evaluation of
patients with a strong response to epithelial –on corneal collagen cross-linking (CXL), ePoster Accepted
for the ISRS subspecialty day meeting, AAO, November 9-10, 2012, Chicago, IL
12.
Poster 363: Rubinfeld R, Trattler, W, Majmudar, P, Epstein, R, Adi, M, Wallace, D, McCall, T, Martin,
N, Letko, E, Intili, A, Perez, G, Multicenter evaluation of trans-epithelial versus epithelial-off corneal
collagen crosslinking (CXL) for keratoconus and post-LASIK ectasia; American Academy of
Ophthalmology Annual Meeting; Orlando, Florida; October 24-25, 2011
13.
E-Poster 101455: Trattler W, Khell J, Perez G, Retrospective evaluation of tecnis multifocal (ZMA00 or
ZMB00) intraocular lenses following phacoemulsifaction in optimized patients; The International
Society of Refractive Surgery (ISRS) Annual Meeting; Orlando, Florida; October 21-22, 2011
14.
E-Poster 101324: Trattler W, Rubinfeld R, Majmudar P, Letko E, Forstot L, Perez G, Berdy G, Schwartz
J, Hatch K, Kaiser C, Baffna S, Wiley W, Evaluation of epithelial-on corneal collagen crosslinking;
ISRS Annual Meeting; Orlando, Florida; October 21-22, 2011
15.
E-Poster 101325: Majmudar P, Rubinfeld R, McCall T, Epstein R, Bowman B, Luchs J, Perez G,
Malahotra R, Trattler W, Evaluation of epithelial-on corneal collagen crosslinking in patients ages 35
or older; ISRS Annual Meeting; Orlando, Florida; October 21-22, 2011
16.
E-Poster101414: Rubinfeld R, Adi M, Intili A, Morgenstern A, Gelender H, Beebe W, Koreshi A,
Trattler W, Perez G, Comparative evaluation of epithelial-on vs epithelial-off corneal collagen
crosslinking (CXL); ISRS; Orlando, Florida; October 21-22, 2011
17.
Poster: Trattler W, Buznego C, Perez G, Kshetrapal A, Katzen L, Khell J, Retrospective evaluation of
tecnis multifocal (ZMA00 or ZMB00) and ReSTOR (SN60D1) intraocular lenses following
phacoemulsifaction; Poster accepted for XXIX Congress of the European Society of Cataract and
Refractive Surgeons (ESCRS), September 17-21, 2011, Vienna, Austria
18.
Poster: Trattler W, Rubinfeld R, Majmudar P, Malhotra R, Schwartz J, Feldman S, Hatch K, Perez G,
Forstot L, Wiley B, Multicenter evaluation of trans-epithelial versus epithelial-off corneal collagen cross
linking (CXL) for keratoconus and post-LASIK ectasia; Poster accepted for ESCRS, September 17-21,
2011, Vienna, Austria
19.
Poster: Luchs J, Buznego C, Trattler W; Asymptomatic or Minimally Symptomatic Blepharitis in
Patients Having Cataract Surgery; ASCRS; San Diego; March 2011
20.
Poster: Kotha A; Singh S; Trattler W; Buznego C; Visual Outcomes of Glaucoma Patients Receiving
Presbyopia-Correcting IOL; ASCRS; San Diego; March 2011
21.
Poster: Singh S, Trattler W, Perez G; Lin D; Crosslinking Followed by Topography-Guided PRK in a
9
William B. Trattler, MD
Commercial Airline Pilot; ASCRS; San Diego; March 2011
22.
Poster: Trattler W, Reilly C, Goldberg D, Majmudar P, Vukich J, Packer M; Donnenfeld E; Cataract and
Dry Eye: Prospective Health Assessment of Cataract Patients Ocular Surface Study; ASCRS;
San Diego; March 2011
23.
Poster: Trattler W; Haytac P; Neal D; Open-Label Evaluation of Degree of Accommodation in
Pseudophakic Patients With Bilateral Monofocal Intraocular Lenses; ASCRS; San Diego; March 2011
24.
Poster PO479 Refractive Outcomes with Advanced CustomVue iLASIK; The American Academy of
Ophthalmology Annual Meeting; Chicago, IL; October 19th, 2010
25.
E- Poster 2042 : Trattler W, Goldberg D, Reilly C, Packer M, Majmudar P, Donnenfeld E, McDonald
M, Vukich J, Berdy G, Malahotra R, Stonecipher K; Incidence of concomitant cataract and dry eye: a
prospective health assessment of cataract patients' ocular surface; The European Society of Cataract and
Refractive Surgery Annual Meeting; Paris, France; September 5th, 2010
26.
E-Poster 1863: Trattler W, Haytac P, Neal D; Open-Label Evaluation of Degree of Accommodation in
Pseudophakic Patients Bilaterally Implanted with Monofocal Intraocular Lenses ; The European Society
of Cataract and Refractive Surgery Annual Meeting; Paris, France; September 5th, 2010
27.
Poster 1888 - Refractive Outcomes with Advanced CustomVue iLASIK; The European Society of
Cataract and Refractive Surgery Annual Meeting; Paris, France; September 5th, 2010
28.
E-Poster 891: Trattler W, Goldberg D, Reilly C, Packer M, Majmudar P, Donnenfeld E, McDonald M,
Vukich J, Berdy G, Malahotra R, Stonecipher K.; Incidence of Concomitant Cataract and Dry Eye;
Prospective Health Assessment of Cataract Patients. World Cornea Congress; Boston Mass; April 8 th,
2010.
29.
Luchs J; Buznego C; Trattler W; Prevalence of Blepharitis in Patients Scheduled for Routine Cataract
Surgery; The American Society of Cataract and Refractive Surgery; Boston Mass; April 12th, 2010.
30.
E-poster 100972. W. Trattler, C. Reilly, S. Coleman, D. Schneider, E. Donnenfeld, R. Maloney and L.
Katzen; Refractive Outcomes With Advanced Customized LASIK; The International Society of
Refractive Surgery Annual Meeting, October 23rd, 2009; San Francisco, CA
31.
Buznego C, Trattler W. Bromfenac BID Plus Prednisolone Acetate BID versus Bromfenac BID Plus
Prednisolone QID for the Prevention of Cystoid Macular Edema and Retinal Thickening; The American
Society of Cataract and Refractive Surgery Annual Meeting, April 2009; San Francisco, CA
32.
Trattler, William B.; Kuhn, Karen L.; Haque, Reza; Zink, Richard C.; Luchs, Jodi; Effect of Topical
Azithromycin on Blepharitis Signs and Symptoms; The American Society of Cataract and
Refractive Surgery Annual Meeting, April 2009; San Francisco, CA
33.
Jess T. Whitson, MD; William B. Trattler, MD; Cynthia Matossian, MD, FACS; Julia Williams, BA,
MA; David A. Hollander, MD, MBAOcular Surface Tolerability of Prostaglandin Analogues (PGAs) in
Patients with Glaucoma or Ocular Hypertension. The American Glaucoma Society, San Francisco, CA;
March 5, 2009
34.
Wachler BB, Trattler W; Ectasia following LASIK with the flap created by a Femtosecond laser;
American Academy of Ophthalmology Annual Meeting; New Orleans, LA; Nov 12, 2007
35.
Trattler W, Rapoza P, Peace J, Chu R, Walters T, Stewart, R, Bianca R, Gow J, McNamara T; for the
Bromfenac Ophthalmic Solution Once Daily Study Group; Integrated Results From Two Phase III
Clinical Trials of a Once-Daily Bromfenac Ophthalmic Solution for Ocular Surgery; The American
Academy of Ophthalmology Annual Meeting; New Orleans, LA; Nov 12, 2007
36.
Trattler W; The Clinical Performance of the Tetraflex Accommodating Posterior Chamber IOL: USFDA
Multicenter Investigation; The American Academy of Ophthalmology Annual Meeting; New Orleans,
LA; Nov 12, 2007
37.
Buznego C, Trattler W; Twelve-Month Analysis of the iStent Trabecular Shunt for the Treatment of
10
William B. Trattler, MD
Primary Open-Angle Glaucoma in Patients Undergoing Phacoemulsification.; 2007 ISRS/AAO Annual
Regional Meeting; Beijing, China. May 27, 2007
38.
Tauber S, Trattler W, Luchs J, Majmudar P; A Randomized, Double-Masked, Contralateral Eye Clinical
Evaluation of Ketorolac 0.4% Versus Nepafenac 0.1% in Photorefractive Keratectomy (PRK) Patients.
Poster presented at ARVO, May 10, 2007
39.
Robert J. Noecker, MD; William Trattler, MD; Melissa L. Earl, MPH. Brimonidine Purite 0.15% versus
Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost; Amerrican Glaucoma Society; San
Francisco, CA; February 2007
40.
Trattler W, Stulting D, Abad J, Speaker M, Gold J, Nasser R, Claringbold T, Majmudar P, Luchs J,
Tauber , S, Binder P; Delayed Epithelial Healing With Nepafenac 0.1% Ophthalmic Suspension;
Presented at: 2006 Joint Meeting of the American Academy of Ophthalmology (AAO) and the Asia
Pacific Academy of Ophthalmology (APAO); November 11-14, 2006; Las Vegas, NV.
41.
Wittpenn J, Silverstein S, Hunkeler J, Schedter B, Price F, Chu R, Wallace B, Trattler W, Solomon K,
Donnenfeld E, Kenyon K, Roberts C. A masked comparison of Acular LS plus steroid versus steroid
alone for the prevention of macular leakage in cataract patients. Presented at: 2006 Joint Meeting of the
American Academy of Ophthalmology (AAO) and the Asia Pacific Academy of Ophthalmology
(APAO); November 11-14, 2006; Las Vegas, NV.
42.
Trattler W, Katzev D, Kerney D. Self-Reported Compliance with Topical Cyclosporine Emulstion
0.05% and onset of Effects of Increased Tear Production. Abstract ARVO May 2006
43.
McDonald MB, Trattler W. Double-Masked Comparison of Ketorolac Tromethamine 0.4% versus
Nepafenac Sodium 0.1% for Postoperative Healing Rates and Pain Control in Eyes Undergoing Surface
Ablation. ARVO April 30, 2006.
44.
J.F. McDonnell, D.A. Montgomery, W. Trattler, B. Larson, and T. Shivan; Scotopic Pupil Size and the
Level of Pre–Operative Myopia as They Relate to the Starburst Phenomenon Following LASER Vision
Correction; Invest. Ophthalmol. Vis. Sci. 2006 47: E-Abstract 53.
45.
M. Yen, G. Alexandrakis, M. Shuler, W. Trattler, & E. Ysasaga, Outcomes of Initial Resident Cataract
Surgery; Comparison of Incisional techniques. The American Society of Cataract and Refractive
Surgery Annual Meeting, May 2000, Boston, MA
46.
M. Shuler, G. Alexandrakis, W. Trattler, M. Yen, & E. Ysasaga, Effect of Cataract Incision Technique
on Postoperative Astigmatism. The American Society of Cataract and Refractive Surgery Annual
Meeting, May 2000, Boston, MA
47.
E. Ysasaga, G. Alexandrakis, M. Shuler, W. Trattler, & M. Yen, Accuracy of Intraocular Lens
Calculations by Resident Surgeons. The American Society of Cataract and Refractive Surgery Annual
Meeting, May ‘00, Boston, MA
48.
S. Goldstein, S. Orlin, M. Maguire, W. Trattler, S. Levy, M. Sulewski, Long Term Survival of
Penetrating Keratoplasty. The Association for Research in Vision and Ophthalmology (ARVO), Annual
Spring Meeting, April 2000, Ft. Lauderdale, FL
49.
McCulley, J.P., Shine, W.E., and Trattler, W. Effects of Minocycline on the Ocular Flora of Patients
with Acne Rosacea & Seborrheic Blepharitis. Inv Ophthalmology Vis Sci. 40 (supp): p. 691, 1999
50.
Trattler W.B., Streilein J.W., and Cousins S.W. The Anterior Chamber is Resistant to Delayed
Hypersensitivity Unless Immune Privilege is Abrogated by Gamma Interferon. Inv Ophthalmology Vis
Sci. 31 (supp): 214, 1990.
Textbooks
11
William B. Trattler, MD
Gladwin, M, Trattler W, Mahan S, Clinical Microbiology Made Ridiculously Simple. A 260 page
textbook; “A brief, clear, thorough, and highly enjoyable approach to clinical microbiology
brimming with mnemonics, humor, summary charts, and illustrations.” Now in Edition 6 (2014);
Medmaster
Trattler W, Majmudar P, Luchs J, Schwartz T, Cornea Handbook; January 2010; Slack Incorporated
Trattler, W. and Gladwin, M. Clinical Microbiology Made Ridiculously Simple. Edition 5 (2011);
Medmaster
Friedman,N., Kaiser, P., Trattler, W. Review of Ophthalmology. Elsevier Saunders; October 2004 A 390
page textbook for detailed review of ophthalmology topics.
Goldberg, S and Trattler, W. Ophthalmology Made Ridiculously Simple. Interactive Edition.
Medmaster. November 2004. 82 page introductory book to ophthalmology topics, with CD ROM
atlas of clinical photos; Medmaster
Chapters in Textbooks:
Salz J & Trattler W: Preoperative Evaluation for Refractive Surgery, Cornea, 2004; pages 1897-1908
Trattler W & Salz J; Preoperative Evaluation of the Prospective Hyperopic Refractive Surgery Patient,
Surgery For Hyperopia; November 2003; pages 44 -54
Published Articles/Interviews in Ophthalmology Journals (Non Peer-Reviewed)
1.
Evading the risk of endophthalmitis; Steps to prevent this rare but potentially catastrophic infection.
Ophthalmology Management; February 2014
2.
EyeWorld; Ocular Surgery News; October 2012
3.
Maximizing Success with Presbyopia-correcting IOLs; Refractive EyeCare; August 2012
4.
Epi-On or Epi-Off? Only Time Will Tell; ISRS Refractive Surgery Outlook; August 2011
12
William B. Trattler, MD
5.
Ectasia Risk Score System; EyeWorld; July 2011
6.
Epithelial-On Crosslinking Growing while Epithelium-off seeks FDA Approval; Ocular Surgery News;
June 2011
7.
Future of excimer laser ablation likely driven by diagnostic assessment tool; Ocular Surgery News; June
2011
8.
Presbyopia Correcting IOL Pearls; EyeWorld June 2011
9.
Don’t Exclude Thin Cornea Patients from LASIK for Fear of Ectasia; EyeWorld; May 2011
10. Impact of Dry Eye On Patient Satisfaction; EyeWorld, April 2011
11. Study: Dry eye may be more prevalent in cataract surgery patients than previously thought; Ocular
Surgery News; March 2011
12. As the primacy of LASIK is challenged as the refractive procedure of choice, what role does the lagging
economy play in contrast to the increasing availability of alternative treatments? Point/Counter Point;
Ocular Surgery News; March 2011
13. Software Handpiece Upgrades Mark Latest Phaco Improvements; EyeWorld; March 2011
14. ASCRS Responds to LASIK critic Morris Waxler; EyeWorld; March 2011
15. Viscoelastic Usage Varies with Conditions; EyeWorld, January 2011
16. Femtosecond lasers minimize role of surface ablation in refractive surgery; Ocular Surgery New;
January 2011
17. To take full advantage of new diagnostic technologies, what steps should IOL manufacturers take to
improve IOL power and sizing? Ocular Surgery News; December 2011.
18. Chief Medical Editors Page: Seventh-Grade Heroes; Advanced Ocular Care; December 2010
19. Macular Function; Cataract & Refractive Surgery Today; Nov 2010
20. EyeTube.net Presents Practical and Challenging Cases;Cataract & Refractive Surgery Today; Nov 2010
21. 5 Questions with William Trattler, MD; Cataract & Refractive Surgery Today; October 2010
22. Incrememtal Improvements offered by New Anti-Infectives; EyeWorld. October 2010
23. Perspective: More than 40% of North African Population has corneal thickness below limit for refractive
surgery; Ocular Surgery News, October 2010
24. Surgical Prophylaxis: Optimizing Drug Selection for Different Patients and Procedures; Topics in
Ocular Antiinfectives; Issue 12, 2010
25. Professional Life and the Smartphone; Cataract & Refractive Surgery Today; September 2010
26. It’s All in the Details; Exploring the fine points on Eyetube.net; Cataract & Refract Surg Today; Sept ‘10
27. Cleaning the Anterior Capsule; Cataract & Refractive Surgery Today; September 2010
28. Henry Trattler, MD & William Trattler, MD; Ocular Injuries in Sports; Advanced Ocular Care; Sept ‘10
29. Chief Medical Editors Page: Benefits of Collaboration; Advanced Ocular Care; September 2010
30. ARVO Roundtable; Cataract & Refractive Surgery Today Supplement; September 2010
13
William B. Trattler, MD
31. Blepharitis 2010: Update on Research and Management; CME Supplement to Ophthalmology Times
32. Loose Epithelium and Adherent LASIK Flap; Cataract & Refractive Surgery Today; August 2010
33. Videos for Premium Practice; Cataract & Refractive Surgery Today; August 2010
34. Fighitng Ocular Infections; EyeWorld; June 2010.
35. Evaluating the scope of keratectomy; EyeWorld; June 2010
36. Chief Medical Editors Page: The Importance of Off-Label Drug Use; Advanced Ocular Care; May ‘10
37. The Importance of the Preoperative Evaluation; Advanced Ocular Care; May ‘10
38. Z syndrome still possible with newer generation Crystalens; EyeWorld; April 2010
39. Connecting diabetes and myopia; EyeWorld; June 2010
40. Optimal Ocular Surface Needed Preop; EyeWorld Supplement; Taking Cataract and Refractive Surgery
to the Next Level; May 2010
41. Where Does your water come from? EyeWorld May 2010
42. eyeCONNECTIONS; Queries about collagen crosslinking; EyeWorld
43. Chief Medical Editors Page: Cause and Effect; Advanced Ocular Care; March 2010
44. Answering Your Patient’s Questions about Collagen Crosslinking; Advanced Ocular Care; March 2010
45. Chief Medical Editors Page: Our Mission; Advanced Ocular Care; February 2010
46. Spotlight on Surface Ablation: Evolving techniques reduce pain, haze associated with surface ablation;
Ocular Surgery News; January 10, 2010
47. Myths and Realities of Post-LASIK Dry Eye (co-author Parag Majmduar MD; Ophthalmology
Management; December 2009
48. First Things First: Maximizing Corneal Health Preop; Review of Ophthalmology; November 2009.
49. A Cornea Specialist Looks at Glaucoma Medications; Refractive EyeCare; October 2009 (Advertorial)
50. Corneal Collagen Cross-linking; Cataract and Refractive Surgery Today; September 2009’
51. Spectacle Independence achieveable, but don’t guarantee it; EyeWorld; September 2009
52. Setting Off Red Flags; ; EyeWorld; September 2009
53. Another Look at Keratoconus; ; EyeWorld; September 2009
54. Could long-term effects of cross-linking be a concern and a potential source of problems; Ocular
Surgery News; September 10, 2009
55. Bacterial Conjunctivitis and its Significance for Ophthalmologists; Topics in Ocular Antiinfectives;
issue #5, 3009.
56. Corneal Topography; Cataract and Refractive Surgery Today; August 2009
57. Must-See Ophthalmic Videos; Cataract and Refractive Surgery Today; August 2009
58. Refractive Surgery on a Thin Cornea; Cataract and Refractive Surgery Today; May 2009
14
William B. Trattler, MD
59. Techniques To Improve The Ocular Surface After Cataract Surgery; Cataract and Refractive Surgery
Today; May 2009
60. Multi-site iLASIK study launched; Early results suggest that combination of technologies provides best
possible laser vision refraction outcome; EyeWorld Supplement; May 2009
61. Debate Over Corneal Thickness for LASIK; EyeNet Magazine; April 2009
62. Collagen Crosslinking: Research Offers Promise and Poses Questions; EyeNet Magazine; April 2009
63. Punctal Plugs/Ophthalmic Insert Can Alleviate Dry Eye; Cataract and Refractive Surgery Today; April
2009
64. Post-LASIK ectasia is not only increased by central corneal thickness; Evidence shows most cases had
abnormal findings preoperatively, not thin corneas, physician says; Ophthalmology Management;
March 2009
65. Strategies For Success With Five Refractive Iols; Cataract and Refractive Surgery Today; May 2009
66. Choosing the Best IOL For Your Patients; Surgeons weigh in on what leads to IOL selection;
EyeWorld; march 2009
67. Infectious Keratitis Rates Higher with Surface Ablation; EyeWorld; March 2009
68. Central Corneal Thickness not a sole factor in post-LASIK ectasia. Evidence shows most cases had
abnormal findings preoperatively, not thin corneas, physician says. Ophthalmology Times; March 2009
69. Spotlight on Advanced Surface Ablation; Latest Techniques aim to limit postoperative complications;
Ocular Surgery News; January 10, 2009
70. Anterior Sutured PCILs May overcome Weak Capsular Support; Eyenet; January 2009
71. Glaucoma and Dry Eye; Getting to the Source of the Problem; Highlights from a Roundtable Discussion
with Glaucoma and Corneal Experts; Pfizer Ophthalmics Supplement; December 2008
72. Definition and Understanding of MGD; EyeWorld; December 2008
73. Standardized digital imaging technique aims to increase understanding of intralenticular glisteninsg;
Ophthalmology Times., October 1, 2008
74. PRK: Feeling Better and Healing Faster; EyeNet, September, 2008
75. Topography and Premium IOL Surgery; Cataract and Refractive Surgery Today; September 2008
76. Preparing the Ocular Surface for Surgery; Establishing a healthy ocular surface and tear film before
surgery can improve postoperative outcomes; Review of Ophthalmology; September 2008
77. Predicting Ectasia After LASIK: Currently available risk calculators may not account for all of the
contributing factors in the development of this serious postoperative complication. Cataract and
Refractive Surgery Today; August 2008
78. Haze and Irregular Astigmatism After PRK; Cataract and Refractive Surgery Today; August 2008
79. Cataract Surgery With Pterygium: Topography is a critical planning tool for challenging cases. Best of
SOURCE Houston; Cataract and Refractive Surgery Today; August 2008
80. Being Proactive in Patients with Sjogren’s; EyeWorld August 2008
81. Understanding the Comparison (Longterm PRK vs LASIK results; EyeWorld August 2008
82. Changing One Letter; EyeWorld August 2008
83. Pinpointing Pink Eye; EyeWorld; August 2008
84. Refractive Surgery Controversies to Dread; Surgeons respond to three touchy situations from the
refractive arena. Review of Ophthalmology; July 2008
85. IOL Calculations: When Millimeters Count; Eyenet; June, 2008
86. Once Daily Bromfenac Safe, Effective Postoperatively; Ophthalmology Times; June, 2008
87. When to avoid PRK; EyeWorld; May 2008
15
William B. Trattler, MD
88. Pollen, Dust & Mold: Seasonal Allergies Assault the Eye; Eyenet; May 2008
89. The Crystalens and a History of Retinal Detachment; Cataract and Refractive Surgery Today; March 08
90. Industry trends toward improved diagnostic technology; EyeWorld;April 2008
91. Comparing surgery results EyeWorld;April 2008
92. Connecting diabetes and myopia; EyeWorld;April 2008
93. The interpretation of Topography Preoperatively; Cataract and Refractive Surgery Today; March 2008
94. My Most Difficult Refractive IOL Case; Cataract and Refractive Surgery Today; March 2008
95. What Treatment Would You Do? Cataract and Refractive Surgery Today; March 2008
96. Calculating ectasia risk factors; EyeWorld March 2008
97. Virgin corneas after E-PRK; EyeWorld; March 2008
98. Cataract surgery innovations; Advances in techniques; EyeWorld; March 2008
99. Results for LASIK and phakic IOL patients compared ; EyeWorld; March 2008
100. Incorrectly diagnosing keratoconus; EyeWorld; March 2008
101. New technique for retreatments; EyeWorld; March 2008
102. Effectively treating ocular allergies; EyeWorld; March 2008
103. Promising topography research; EyeWorld; March 2008
104. SF6 effective in managing corneal hydrops? EyeWorld; March 2008
105. Cataract surgery innovations: Femtosecond laser incision techniques; EyeWorld; March 2008
106. EyeMail Insights: Pterygium and mitomycin C; EyeWorld; March 2008
107. HOAs and fantastic vision not mutually exclusive; EyeWorld; February 2008
108. Oblique viewing could affect refraction; EyeWorld; February 2008
109. The Thick and Thin of Ectasia; Eyenet Magazine; January 2008
Also reprinted in “The Best of Cataract & Refractive Surgery Supplement” for AAO Subspecialty
Day; November 2008
110. Dynamics of coma development; Eyeworld; Jan 2008
111. Donnenfeld, Trattler, Buznego; The Relationship Between Dry Eye and Cataract Surgery: Pre-existing
dry eye can affect IOL calculations, and dry-eye induced by cataract surgery can affect visual outcomes.
Review of Ophthalmology, November 2007
112. Collagen cross-linking after PRK; EyeWorld; November 2007
113. Seeing red over the refraction charge: EyeWorld; November 2007
114. Challenging Cataract Cases: The most challenging cataract cases: EyeWorld; October 2007
115. Challenging Cataract Cases: Capsular rupture … the new solution; EyeWorld; October 2007
116. PMD or Keratoconus? Eyeworld; September 2007
117. Trattler, Buznego; Pearls for Success With Presbyopia-Correcting IOLs; The authors provide their
pre-, intra-, and postoperative tips and tricks for improved outcomes ; Cataract & Refractive Surgery
Today; Sept 2007
118. Point/Counterpoint: Is Corneal Thickness a Risk Factor for Post-LASIK Ectasia? ; Cataract &
Refractive Surgery Today; September 2007
119. To diamond cut or not; Eyeworld; September 2007
120. Delayed Epithelial Healing After Surface Ablation
121. Dry Eye Gets Some Respect; Eyenet Magazine; August 2007
16
William B. Trattler, MD
122. Case Study: Losing a LASIK Flap During a LASIK Procedure; Ocular Surgery News; August 15, 2007
123. Clinical Update: Eye on Eye Medicine, Part Fou; World Wide Medicine: When Patients Surf the Web;
Eyenet Magazine; August 2007
124. Preliminary analyses point to efficacy of once-daily NSAID: New bromfenec ophthalmic solution can
control pain, inflammation after cataract surgery; Ophthalmology Times; July 2007
125. Case study: Accidental corneal transplant dehiscence; Physicians discuss how to prevent infection
when the anterior segment is open and the cornea is contaminated; Ocular Surgery News, June 2007
126. Eye drop offers action at surface, cellular levels: Could be 1st-line therapy for dry eye and in
conjunction with topical cyclosporine; Ophthalmology Times; May 2007
127. Incomplete blinking may be connected to keratopathy after LASIK; EyeWold. May 2007
128. Microbial keratisis threatens contact lens wearers; EyeWold. May 2007
129. Ocular infection linked to IBD; EyeWorld. May 2007
130. Haze treatment versus haze prevention; EyeWorld. May 2007
131. Orthokeratology: commend or condemn? EyeWorld. May 2007
132. Minimizing Night Vision Problems in Patients with Large Pupils; Refractive Eye Care; May 2007
133. Panel examines NSAID use in surface ablation procedures, part 2 (Lindstrom D; Durrie D; Gayton J;
O’Brien T; Trattler W); Ocular Surgery News; April 2007
134. Panel explores clinical considerations of NSAID use in surface ablation patients, part 1 (Lindstrom D;
Durrie D; Gayton J; O’Brien T; Trattler W); Ocular Surgery News; April 2007
135. Patients with corneal infiltrates; This month’s Corneal Health column focuses on identifying cases of
infectious infiltrations; Ocular Surgery News; April 2007
136. EyeMail Insights: Standards for a one-eyed cataract surgery candidate; EyeWorld; April 2007
137. Ocular Allergies Common, Causes are not; EyeWorld; March 2007
138. Minimizing Postoperative Discomfort; Cataract and Refractive Surgery Today; Feb 2007
139. Use of surface ablation increasing; Experts debate its future; Ocular Surgery News. Jan 1, 2007
140. NSAID regimen important in perioperative care of laser surface ablation patients: ; Ocular Surgery
News. Jan 1, 2007
141. Advanced surface ablation finding increasing role in refractive surgery, surgeon says; OSN Supersite
Breaking News 11/22/06
142. Treatment for Patients with Dry Eye Pre- & Postop; Ophthalmology Management; Dec 2006
143. Surgeon: Pain control key to maximizing surface ablation outcomes; Ocular Surgery News; Nov 15, 06
144. Surgeon: Pain control key to maximizing surface ablation outcomes; OSN Supersite Top Story 10/17/06
145. Point/Counterpoint:LASIK vs Surface Ablation; Cataract & Refractive Surgery Today; Oct 2006
146. Surface Ablation Prophlactic: Vitamin C or Mitomcin C; Ophthalmology Management, Sept 2006
147. The Role of NSAIDs and Their Surgical Applications; Surgical applications for NSAIDs; Ocular Surgery
News Monograph; Sept 1, 2006
148. Surface Ablation for Keratoconus. Cataract & Refractive Surgery Today, August 2006.
149. Slade, Springs C; Trattler W, Woodhams T: Classifying Keratoconus: Surgeons discuss how they define
mild keratoconus, keratoconus, and forme fruste keratoconus, and they share their top indices for
distinguishing between the three corneal states. Cataract & Refractive Surgery Today, August 2006.
150. Doane J, Binder P. Majmudar P, Probst L, Slade S, Trattler W: What is your Diagnosis? Surgeons
discuss their analyses of various topographies of possibly keratoconus cases and converse about their
treatment recommendations. Cataract & Refractive Surgery Today, August 2006.
151. Aggressive Treatment of Post-LASIK Dry eye; Ophthalmology Management; July 2006
17
William B. Trattler, MD
152. Post-LASIK Dry Eye; Case Presentation and Answers: Cataract & Refractive Surgery Today; June 2006
153. Experience with Acuvue® Oasys™ as a Bandage Lens, Refractive Eye Care, June 2006
154. Letter to the Editor; Response to Terry O’Brien’s question on Nevanac and delayed epithelial Healing;
Cataract & Refractive Surgery Today, June 2006
155. In hands of experts, surface ablation has many variations; Leading surgeons shared their surface
ablation surgical techniques & explain why they perform the procedure the way they do. OSN May ‘06
156. Letter to the Editor; Response to Johnny Gayton’s question on Nevanac and delayed epithelial Healing;
Cataract & Refractive Surgery today, June 2006
157. Topical NSAIDS for Pain And inflammation; Review of Ophthalmology, May 2006
158. LASIK Buttonhole After Cataract Surgery: Case Presentation and Answers; Cataract & Refractive
Surgery Today; April 2006
159. Ketorolac vs. Nepafenac Study: Toxicity Delays Epithelial Healing in Nepafenac-Treated Eyes; Eye
World Supplement, April 2006
160. NSAIDs and Delayed Healing; Cataract & Refractive Surgery Today; March 2006
161. Are Surface Enhancements safe? Review of Ophthalmology, March 2006
162. Breaking New Ground: Lasers in Keratoconus; Surgeons are taking a look at certain kinds of refractive
surgery in patients others might not operate on. Review of Ophthalmology, March 2006
163. The Role of NSAIDS following Surface Ablation, Ocular Surgery News Supplement, Feb 2006
164. Enhancement Following Epi-LASIK; Cataract & Refractive Surgery Today; Feb 2006
165. Roundtable Participants Discuss Advanced Surface Ablation; Primary Care Optometry News; Jan 2006
166. Round Table Discussion: Surface Ablation; Ocular Surgery News, October 2005
167. Known Risk Factors for Ectasia: What do we know so far? Cataract & Refractive Surgery Today, Oct‘05
168. Volpicelli M, Trattler W; Epi-LASIK: The Procedure, Pain Management and Patient results;
Ophtalmology Management Sept 2005
169. Mast Cell Stabalizers Ideal For Giant Pappillary Conjunctivitis; Ophthalmology Times, September 2005
170. Pupil Size, Accommodation Among Hot Summer Refractive Topics; EyeWorld, September, 2005
171. Can Large Pupils Lead to Poor Vision After LASIK; EyeWorld, September, 2005
172. Adam Crawford; Retired Physician Writes “Simple” Books; EyeWorld, September 2005
173. The Role of Lipid-Containing Artificial Tears in Refractive Surgery; Supplement, Refractive Eyecare;
June 2005
174. David Meadows, Ph.D., William Trattler, MD, Jeffrey Gilbard, MD, Peter Simmons, Ph.D. Science
Behind Today’s Artificial Tears; The science and mechanism of action behind today’s most unique
formulations. Ophthalmology Management, June 2005
175. Lose the Pain, But Keep the Gain: Getting good results with refractive surface procedures doesn't have
to Hurt.; Review of Ophthalmology; June 2005
176. New intracanalicular punctum plug relieves dry eye; Ophthalmology Times May15, 2007
177. Refractive Surgery: Insight on Ectasia; Review of Ophthalmology, March 2005
178. Helpful Ways to Prevent and Treat Ectasia; EyeWorld, March, 2005
179. W. Trattler, MD. LASEK Wound Healing with Fourth Generation Fluoroquinolones. EyeWorld
Supplement, Feb. 2005
180. Study Finds Correlation between night vision troubles, larger pupils; EyeWorld, February 2005
181. Are Surface Enhancements Safe? Review of Ophthalmology; Nov. 2004
18
William B. Trattler, MD
182. W. Trattler, MD & Dan Durrie, MD. Newer Fluoroquinolones preferred antimicrobial prophylaxis.
Patients undergoing excimer laser refractive procedures can be assured of broad-spectrum coverage.
Ophthalmology Times; November 1, 2004. page 21.
183. Fourth Generation Fluoroquinolones’s effect on LASEK. EyeWorld Supplement Oct. ‘04
184. Fluoroquinolone Choice Does Not Affect Wound Healing in LASEK, Refractive Eye Care,Oct 2004
185. Learning From Our Refractive Surgery Patients; Refractive Eye Care; July 2004
186. Combination Therapies for Dry Eye Patient, Cataract & Refractive Surgery Today Feb‘04
187. Surface ablation pain-control techniques continue to evolve, Eyeworld, December 2003
188. W Trattler, MD & Jodi Luchs, MD Mast Cell Stabalizers Help with Chronic Allergic Symptoms,
Ophthalmology Times, September 2003
189. Understanding Postsurgical Haze, Cataract & Refractive Surgery Today, March 2003
190. Can Surface Ablation Be Used to Enhance or Complete LASIK Procedures?, Refractive Eye Care, Nov
2002
191. Websites to Watch, Review of Ophthalmology, January 2001
192. D. Ruriani. Complicated Cases: Creatively Managing Microstriae. Eye World. July 2000
193. LASIK and Dry Eye – The Connection; Case Management for Improved Outcomes and Patient
Satisfaction. Ophthalmology Management Supplement, April 2000
194. What to Know Before You Launch Your Website, Review of Ophthalmology, March 2000
195. Complicated Cases: Superficial microkeratome pass. EyeWorld, Feb 2000
196. T. Henderson, MD, W. Hill, MD, William Trattler, MD, et al. Complicated CasesLensectomy and IOL
implantation with Marfan’s habitus. Eye World Jan. 2000
197. W. Bethke, Patients and the Web: The Psychology of the Search. Review of Ophthalmology, Dec 1999
198. R. Fellman, S. Ullman, W. Trattler, et al. Complicated Cases: Cataract extraction for pseudoexfoliation
with phacodonesis. Eye World. November 1999
Chapters in Online Textbooks
Trattler, W. & Clark, W. Macular Corneal Dystrophy. Emedicine.com, June 2000
Trattler, W. & Clark, W. Granular Corneal Dystrophy. Emedicine.com, July 2000
Trattler, W. & Clark, W. Lattice Corneal Dystrophy. Emedicine.com, June 2000
Clark, W, Kaiser, P & Trattler, W. Postoperative Endophthalmitis. Emedicine.com, June 2000
SCIENTIFIC MEETINGS
1. Meeting Organizer with Ronald Krueger, MD, Richard Yee, MD, & Daniel Durie, MD: The 13th International
Congress on Surface Ablation and Sub Bowman's Keratomileusis; Deer Valley, Utah, July 2014
2. Meeting Organizer with Steven Dell, Robert Cionni MD, Michael Knorz MD, William Link PhD, Tal Raviv MD,
Stephen Slade MD, and George Waring IV MD; AECOS Summer Meeting; Deer Valley; July 24-27th 2014
3. Meeting Organizer with Ronald Krueger, MD, Richard Yee, MD, & Daniel Durie, MD: The 12th International
Congress on Surface Ablation and Sub Bowman's Keratomileusis; Deer Valley, Utah, July 2013
4. Meeting Organizer with Ronald Krueger, MD, Richard Yee, MD, & Daniel Durie, MD: The 11th International
Congress on Surface Ablation and Sub Bowman's Keratomileusis; Deer Valley, Utah, July 2012
5. Meeting Organizer: The ACOS PresbyOscars Sympsium of Presbyopia and Femtosecond Cataract Surgery:
June 29th to July 1, 2012. Cannes, France
19
William B. Trattler, MD
6. Meeting Organizer: The International Society of Refractive Surgery Symposium at the European Society of Cataract
and Refractive Surgery. Controversies in Laser Refractive Surgery, Corneal Collagen Crosslinking, and Presybyopic
IOLs. September 21st, 2011. Vienna, Austria
7. Meeting Organizer with Ronald Krueger, MD, Richard Yee, MD, & Daniel Durie, MD: The 10th International
Congress on Surface Ablation and Sub Bowman's Keratomileusis; Deer Valley, Utah, July 31-Aug. 1, 2011
8. Meeting Organizer with Ronald Krueger, MD, Richard Yee, MD, & Daniel Durie, MD: The 9th International
Congress on Surface Ablation and Sub Bowman's Keratomileusis; Ft. Lauderdale, FL; May 1, 2010
9. Meeting Organizer: The International Society of Refractive Surgery Symposium at the European Society of Cataract
and Refractive Surgery. Controversies in Laser Refractive Surgery, Corneal Collagen Crosslinking, and Presybyopic
IOLs. September 7th, 2010. Paris, France
10. Meeting Organizer with Ronald Krueger, MD, Richard Yee, MD, & Daniel Durie, MD: The 8th International
Congress on Surface Ablation and Sub Bowman's Keratomileusis; Ft. Lauderdale, FL, May 2, 2009
11. Meeting Organizer with Ronald Krueger, MD, Richard Yee, MD, & Daniel Durie, MD: The Seventh International
Congress on Surface Ablation and Sub Bowman's Keratomileusis; Ft. Lauderdale, FL, April 26, 2008
12. Meeting Organizer with Ronald Krueger, MD, Richard Yee, MD, & Daniel Durie, MD: The Sixth International
Congress on Surface Ablation and Sub Bowman's Keratomileusis; Ft. Lauderdale, FL, May 5, 2007
13. Meeting Organizer with Ronald Krueger, MD, Richard Yee, MD, The Fifth International Congress on Epi-LASIK &
LASEK, & Advanced Surface Ablation; London, UK; Sept 8, 2006
14. Meeting Organizer with Ronald Krueger, MD, Richard Yee, MD, & Massimo Camellin, MD, The Fourth International
Congress on Epi-LASIK & LASEK, & Advanced Surface Ablation; April 2005, Ft. Lauderdale, FL
PRESENTATIONS AT REGIONAL OR NATIONAL MEETINGS
1. FP-5345 - First year experience with femto laser cataract surgery: lessons learned; European Society of Cataract and
Refractive Surgery (ESCRS); London, England; September 15, 2014
2. Pearls and Pittfalls in Corneal Topography Interpretation; Indian International Implant and Refractive Surgery Convention;
Chennai, India; July 6, 2014
3. Controversies in Corneal Collagen Crosslinking; Indian International Implant and Refractive Surgery Convention; Chennai, India;;
July 5, 2014
4. Controversy as to when to Perform CXL; AECOS Barcelona; Barcelona, Spain, June 29th, 2014
5. Crosslinking; Florida Society of Ophthalmology Annual Meeting; June 2014
6. Innovations in Pterygium Surgery; Kiawah Eye 2014; Kiawah, SC; June 2014
7. Surprising Findings with Topography; Kiawah Eye 2014; Kiawah, SC; June 2014
8. Update on Crosslinking; Kiawah Eye 2014; Kiawah, SC; June 2014
9. Challenges and Opportunities for Crosslinking Technologies: Ophthalmology Innovation Summit; April 2014; Boston,
MA
10. Optimizing the Results of Presbyopic IOLs; XIII Congresso Internacional de Catarata E Cirurgia Refrativa
Rio, April 4, 2014
11. Improving Outcomes for Refractive Surgery Patients; XIII Congresso Internacional de Catarata E Cirurgia Refrativa
Rio de Jainero, Brazil, April 3, 2014
20
William B. Trattler, MD
12. The Management of Astigmatism in Patients Scheduled for Cataract Surgery; XIII Congresso Internacional de Catarata
E Cirurgia RefrativaRio, April 3, 2014
13. Refractive Surgery Complications, video presentation; XIII Congresso Internacional de Catarata E Cirurgia Refrativa
Rio, April 3, 2014
14. Update on Femto Cataract Surgery; ACOS Aspen Invitational Refractive Symposium; Feb 25 th, 2014; Aspen, CO
15. Refractive Surgery Case Report: High Myopia and astigmatism – surgical Options. Bascom Palmer Cataract and
Refractive Surgery Congress; February 21st, 2014; Miami, FL
16. Medical-legal Issues in Refractive Surgery: Aspen Corneal Society Meeting; February 18th, 2014; Snowmss, CO
17. Update on CXL; Aspen Corneal Society Meeting; February 17th, 2014; Snowmss, CO
18. New Platforms and Integrations in Femtosecond Cataract Laser Surgery: Femto AKs; ACES/SEE Caribbean Eye
Meeting, Cancun, Mexico; Feb 2014
19. What’s New in My Bag: Best and Worst of 2013: Results of PRK/LASIK following Presbyopic IOLs; ACES/SEE
Caribbean Eye Meeting, Cancun, Mexico; Feb 2014
20. My Best or Worst from 2013: Lighter than AIR; ACES/SEE Caribbean Eye Meeting, Cancun, Mexico; Feb 2014
21. Challenges on topographic Interpretation; Med-legal Issues; ACES/SEE Caribbean Eye Meeting, Cancun,; Feb 2014
22. Pearls and Pitfalls with Corneal Collagen Crosslinking; Royal Hawaiian Eye Meeting; Kauai, HI, January 24, 2014
23. Post-cataract Surgery Inflammation and Pain: Prevention and Treatment; Bausch and Lomb Breakfast Symposium;
Royal Hawaiian Eye Meeting; Kauai, HI, January 23 2014
24. Premium IOL Pathway; Preoperative Evaluation of the Cornea; Zeiss Symposium; Royal Hawaiian Eye Meeting;
Kauai, HI, January 21, 2014
25. Femto AKs; Royal Hawaiian Eye Meeting; Kauai, HI, January 21, 2014
26. Techniques for Enhancing Cataract Surgery Patients with Residual Refractive Error; Royal Hawaiian Eye Meeting;
Kauai, HI, January 20, 2014
27. Ophthalmology’s Future Leaders; Evening Symposium sponsored by AMO, with Georege Waring IV, MD, Elizabeth
Davis, MD and Bill Wiley, MD, in New Orleans November 16 th, 2013
28. Update in Corneal Collagen Crosslinking; 12th Annual Downeast Ophthalmology Symposium; Bar Harbor, Maine;
September 22, 2013
29. Preoperative Evaluation of the Cataract Surgery Patient; 12th Annual Downeast Ophthalmology Symposium; Bar
Harbor, Maine; September 21, 2013
30. Controversies in Refractive Surgery; 12th Annual Downeast Ophthalmology Symposium; Bar Harbor, Maine;
September 21, 2013
31. Advanced Diagnostic Technologies for the Evaluation of Refractive Surgery Candidates. The International Military
Refractive Surgery Symposium, San Antonio, TX; Jan 9, 2012
32. Corneal Collagen Crosslinking; International Military Refractive Surgery Symposium, San Antonio, TX; Jan 9, ‘12
33. Controversies in Presbyopic IOLs and Femtosecond Lasers; OSN Symposium 2011; New York, NY, Nov. 20, 2011
34. Update on Corneal Collagen Crosslinking; Ocular Surgery News Symposium 2011; New York, NY, Nov. 19, 2011
35. What is New in LASIK over the Past 4 Years; OSN Symposium 2011; New York, NY, Nov. 19, 2011
21
William B. Trattler, MD
36. Optimizing the Results of Presbyopic IOLs; The American Academy of Ophthalmology Annual Meeting; Orlando, FL;
October 24th, 2011
37. Controversies in Crosslinking; APEX Symposium; Orlando, FL; October 24 th, 2011
38. Pentacam Lecture at Oculus Booth; The AAO Annual Meeting; Orlando, FL; Oct. 23rd, 2011
39. Femtosecond Cataract Surgery course; The AAO Annual Meeting; Orlando, FL; Oct. 23rd, 2011
40. Risk Factors for Ectasia; The International Society of Refractive Surgery Subspecialty Meeting; Orlando, FL; Oct.
21st, 2011
41. Corneal Collagen Crosslinking; The American College of Ophthalmic Surgeons Annual Summit; Orlando, FL; Oct.
21st, 2011
42. Risk Factors for Ectasia; Eurokeratoconus II; Bordeaux, France; September 23 th, 2011
43. Risk Factors for Ectasia; The European Society of Cataract & Refractive Surgery Annual Meeting; Vienna, Austria;
September 20, 2011.
44. CXL in Higher Risk Patients; The 10th International Congress on Surface Ablation and Sub Bowman's Keratomileusis;
Deer Valley, Utah, July 31, 2011
45. Complications Video Case Presentations; Moderator: Kiawah Eye; Kiawah, South Carolina; June 4, 2011
46. Interactive Cornea Program: Risk Factors For Ectasia in Eyes with Normal Topography; Kiawah Eye; Kiawah, South
Carolina; June 3, 2011
47. Reality Ophthalmology – Surviving the Unhappy Patient; Kiawah; Eye; Kiawah, South Carolina; June 3, 2011
48. Buznego C, Trattler W; Assessment of Duration of Effect of Commercially Marketed Over-the-Counter Ocular
Lubricants. ASCRS; San Diego, CA; March 29, 2011
49. Advances in Corneal Collagen Crosslinking for Keratoconus, Post-LASIK Ectasia, and Corneal Infections; ASCRS;
San Diego, CA; March 29, 2011
50. Femtosecond Laser-Assisted Refractive Cataract Surgery; ASCRS; San Diego, CA; March 28, 2011
51. Controversies in Presbyopia-Correcting IOL Surgery; ASCRS; San Diego, CA; March 28, 2011
52. Clinical Pearls for Premium IOLs: 2011 Update; ASCRS; San Diego, CA; March 27, 2011
53. Preoperative Evaluation of the Refractive IOL Patient; Part of Symposium: Taking Your Intraocular Refractive Practice
to the Next Level; ASCRS; San Diego, CA; March 27, 2011
54. Trattler W, Reilly C, Coleman S, Schneider; Donnenfeld E, Maloney R, Katzen L; Refractive Outcomes With
Advanced Wavefront-Guided Ablation Customized LASIK. ASCRS; San Diego, CA; March 26, 2011
55. Controversies in Refractive Surgery; ASCRS; San Diego, CA; March 26, 2011
56. Controversies in Identifying Risk Factors for Post-LASIK Ectasia; ASCRS; San Diego, CA; March 26, 2011
57. Delivering Solid Intermediate and Near Vision with Presbyopic IOLs ; EyeWorld Symposium; March 26, 2011; San
Diego, CA
58. Delivering Patient Satisfaction in Refractive IOL Surgery; ; EyeWorld Symposium; March 26, 2011; San Diego, CA
59. Using Outcomes Data to Select the Ideal Excimer Laser Treatment for the Individual Patient; AMO VISX Users
Meeting; March 24, 2011; San Diego, CA
22
William B. Trattler, MD
60. Controversies in Refractive IOLs. Ocular Surgery News New York 2010; 11/19/2010; New York, New York
61. Delivering Patient Satisfaction in Refractive IOLs Symposium; Ocular Surgery News New York 2010; 11/20/2010;
New York, New York
62. The Perioperative Pharmacological Management of Surface Ablation & LASIK Patients; Ocular Surgery News New
York 2010; 11/2-/2010; New York, New York
63. Five Steps to Endophthalmitis Prevention; Ocular Surgery News New York 2010; 11/19/2010; New York, New York
64. Management of Astigmatism During Cataract Surgery; XXXII Inter-American Course in Clinical Ophthalmology;
Bascom Palmer Eye Institute’s Annual Meeting, October 24, 2010; Miami, FL
65. Risk Factors for Post-LASIK Ectasia. APEX (18th Annual Meeting); October 17th, 2010. Chicago, IL
66. Case Report: LASIK in Large Pupil patient; CRST Focus Group; August 10, 2010
67. Preoperative Evaluation of the Presbyopic IOL Patient; CRST Focus Group; August 10, 2010
68. Corneal Collagen Crosslinking; Canadian Ophthalmology Society; Quebec, Canada; June 28, 2010
69. Preoperative Evaluation of Cataract Surgery; Canadian Ophthalmology Society; Quebec, Canada; June 28, 2010
70. Risk Factors for Post-LASIK Ectasia; Canadian Ophthalmology Society; Quebec, Canada; June 27, 2010
71. Keratoconus; Canadian Ophthalmology Society; Quebec, Canada; June 27, 2010
72. Preoperative Evaluation of Presbyopic IOL Patients; Canadian Ophthalmology Society; Quebec, Canada; June 27, 2010
73. PRK vs LASIK for enhancements in Dry Eye Patients; Aspen Invitational Refractive Symposium; Aspen, CO; March
9th, 2010
74. Corneal Collagen Crosslinking; Aspen Invitational Refractive Symposium; Aspen, CO; March 9 th, 2010
75. Advances In Cataract Surgery: Optimizing Presbyopic IOLs with Intraoperative Aberrometry; 2010 Advanced
Refractive Symposium in Deer Valley
76. Update on Corneal Collagen Cross-linking; Aspen Corneal Society; Snowmaass. Colorado; Feb 18th, 2010
77. Risk Factors for Post-LASIK Ectasia; Aspen Corneal Society; Snowmaass. Colorado; Feb 18 th, 2010
78. Preoperative Evaluation of Cataract Surgery Patients (with Paul Karpecki, OD); South East Congress of Optometry
(SECO); Atlanta; GA; Feb11th, 2010
79. Quantative measurement of Accommodation in Pseudophakic Eyes; Royal Hawaiian Eye; Kauai, HI; ; Jan 22, 2010
80. Quantative measurement of Accommodation in Phakic and Pseudophakic Eyes; Royal Hawaiian Eye; Kauai, HI; ; Jan
18, 2010
81. Preoperative Evaluation of Refractive IOL Patients; Royal Hawaiian Eye Non-CMe Lunch Symposium; Kauai, HI; ;
Jan 17, 2010
82. Identifying Surgical Candidates; Royal Hawaiian Eye CME Breakfast Symposium; Kauai, HI; Jan 17, 2010
83. Premium Refractive IOL Management and Education (PRIME); October 25, 2009; San Francisco, CA
84. The Rise of the Refractive IOL; Who Wants to Be a Multifocal Millionaire Game show; October 24, 2009; San
Francisco, CA
23
William B. Trattler, MD
85. The Perioperative Pharmacologic Management of Surface Ablation and LASIK Patients; OSN New York; Sept 25,
2009; New York, NY
86. Controversies in Refractive IOLs: Symposium Moderator; OSN New York; Sept 25, 2009; New York, NY
87. Corneal Health Roundtable; OSN New York; Sept 25, 2009; New York, NY
88. Pseudophakic IOL Measurements of Accommodation; International Society of Presbyopia Annual Meeting; September
11, 2009; Barcelona, Spain
89. Incorporating Both Multifocal and Accommodating Lenses; What Is Your Thinking Today? Advanced Refractive IOL
Symposium; August 17, 2009; Aspen, CO
90. IOL Materials Impact on Visual Results; Advanced Refractive IOL Symposium; August 17, 2009; Aspen, CO
91. Update on Corneal Collagen Crosslinking for Keratoconus and Post-LASIK ectasia; Florida Society of Ophthalmology
Annual Meeting; July 12, 2009
92. Improving Refractive Outcomes; A Look Towards the Future; June 29, 2009; Atlanta, GA
93. Improving Refractive Outcomes; A Look Towards the Future; June 8, 2009; Dallas, TX
94. Complications Video Case Presentations; Update on Risk Factors for Post-LASIK Ectasia; Kiawah Eye 2009; May 31,
2009; Kiawah Island, SC;
95. Cataract Spotlight: Hot Topics; Management of the Small pupil; Kiawah Eye 2009; May 30, 2009; Kiawah Island, SC;
96. Improving Refractive Outcomes; A Look Towards the Future; May 12, 2009; Ft. Lauderdale, FL
97. Surface Ablation for Forme-Fruste Keratoconus; The 8th international Congress on Surface Ablation & SBK; May 2,
2009; Ft. Lauderdale, FL
98. Risk Factors for Ectasia The 8th international Congress on Surface Ablation & SBK; May 2, 2009; Ft. Lauderdale, FL
99. Azasite Frequently Asked Questions; Inspire Speaker Training; Las Vegas, NV; Feb 28, 2009
100. Update on Corneal Collagen Crosslinking; Aspen Corneal Society; Snowmass, FL February 18 th, 2009;
101. Lid Margin Disease; Aspen Corneal Society; Snowmass, FL February 18th, 2009;
102. Risk Factors for Post-LASIK Ectasia; Aspen Corneal Society; Snowmass, FL February 17 th, 2009;
103. Risk Factors for Post-LASIK Ectasia; Bascom Palmer’s Cataract & Refractive Surgery Congress; Miami, FL; Feb 7,
09
104. Surface Ablation to Enhance Previous LASIK; Royal Hawaiian Eye; Maui, HI; Jan 23, 2009
105. Keys to Success with Premium Lens Patients; Part of Royal Hawaiian Eye Breakfast CME Symposium entitled
Clinical Essentials to Address Perioperative Inflammation; Maui, HI; Jan 20, 2009
106. Blepharitis/Lid Margin Disease and the Surgical Eye: Clinical Cases and Management Considerations; Part of Royal
Hawaiian Eye Lunch CME Symposium entitled Lid Margin Disease: Impact on Patient Health & Surgical Results;
Maui, HI; Jan 18, 2009
107. The Effects of Dysfunctional Tear Film on Surgical Outcomes of Corneal Refractive Surgery; Part of Royal Hawaiian
Eye Breakfast CME Symposium entitled Quality of Vision & Ocular Surface Disease; Maui, HI; Jan 18, 2009
108. Risk Factors for Ectasia; Bascom Palmer’s Inter-American Course in Clinical Ophthalmology; Miami, FL; Nov
18,2008
24
William B. Trattler, MD
109. Corneal Cross-Linking; Bascom Palmer’s Inter-American Course in Clinical Ophthalmology; Miami, FL; Nov
18,2008
110. Thin Corneas and Risk For Post-LASIK Ectasia; PRK, EpiLASIK, LASEK & LASIK Nightmares: Complications in
Refractive Surgery Course; American Academy of Ophthalmology (AAO) Annual Meeting; Atlanta, GA; Nov. 10, ‘08
111. Optimizing the Results of Presbyopic IOL Surgery Course; AAO Annual Meeting; Atlanta, GA; Nov. 9, ‘08
112. High Resolution WaveFront technology; Achieving & Maintaining Success in a Refractive Surgery Environment; Eye
World Symposium; Atlanta, GA; Nov. 9, ‘08
113. Intraocular Lens Biomaterial Considerations; AMO Booth Symposium; AAO; Atlanta, GA; Nov 8, 2008
114. Azasite; Atlanta, GA; Nov 8, 2008
115. Are thin corneas a risk factor for ectasia; Refractive Subspecialty day; AAO Annual Meeting; Atlanta, GA; Nov. 8, ‘08
116. Assessing the Randleman Risk Score System for Predicting Post-LASIK Ectasia in Eyes Without Forme Fruste
Keratoconus; Intralase Users Meeting; Atlanta, GA
117. Preoperative Evaluation of Presbyopia Correcting IOL Patients; Superior Outcomes through Refractive and Cataract
Education (SOURCE); October 11, 2008; Miami, FL
118. Z-Syndrome with the Crystalens; Superior Outcomes through Refractive and Cataract Education (SOURCE);
October 11, 2008; Miami, FL
119. Challenging Presbyopic IOL Cases; Superior Outcomes through Refractive and Cataract Education (SOURCE);
October 11, 2008; Miami, FL
120. Perioperative Medications with Surface Ablation; Ocular Surgery News (OSN) Symposium; OSN York; October 5,
‘08
121. Results of the US FDA Clinical Trial of the Tetraflex Accommodative IOL; Refractive IOL Symposium; Las Vegas,
NV, September 27th, 2008
122. Optimizing Outcomes in Refractive Surgery; Ocular Surgery and Infection: Evaluating the Therapeutic Options;
Allergan Program; Washington DC, September 13, 2008
123. Preoperative Evaluation of Presbyopia Correcting IOL Patients; Superior Outcomes through Refractive and Cataract
Education (SOURCE); September 6, 2008; New Port Beach, CA
124. Z-Syndrome with the Crystalens; Superior Outcomes through Refractive and Cataract Education (SOURCE);
September 6, 2008; New Port Beach, CA
125. Challenging Presbyopic IOL Cases; Superior Outcomes through Refractive and Cataract Education (SOURCE);
September 6, 2008; New Port Beach, CA
126. Pearls for Reducing Ectasia; Summer Advanced Refractive Invitational 2008; Aspen, CO; July 22,2008
127. Risk Factors for Post-LASIK Ectasia, and Corneal Collagen Cross-linking; Virginia Society of Ophthalmology;
Leesburg, VA; June 6th, 2008
128. Preoperative Evaluation of Presbyopia Correcting IOL Patients; Superior Outcomes through Refractive and Cataract
Education (SOURCE); May 31, 2008; Houston, TX
129. Dosing and Comparison of Topical NSAIDS; Superior Outcomes through Refractive and Cataract Education
(SOURCE); May 31, 2008; Houston, TX
130. What would you do (Presentation of Suprachoroidal Hemorrhage during IOL positioning) Superior Outcomes through
Refractive and Cataract Education (SOURCE); May 31, 2008; Houston, TX
25
William B. Trattler, MD
131. Why Corneal thickness does not predict ectasia risk; Symposium on Laser Refractive Surgery; 13th Annual Joint
Meeting Of OSN, SOI & AICCER; May 10, 2008; Naples, Italy
132. The Case for SBK as the Ideal Procedure; Symposium on Laser Refractive Surgery; 13th Annual Joint Meeting Of
OSN, SOI & AICCER; May 10, 2008; Naples, Italy
133. Ocular Surface Disease and Osmoprotection; Symposium on Laser Refractive Surgery; 13th Annual Joint Meeting Of
OSN, SOI & AICCER; May 10, 2008; Naples, Italy
134. Transitioning from Surface Ablation Back to LASIK; iLASIK Symposium; Naples, Italy; May 9, 2008
135. Risk Factors for Ectasia – A Practical Approach; ASCRS; Chicago, IL; April 7, 2008
136. Using Digital Images to Assess the Visual Impact of Glistenings; ASCRS; Chicago, IL; April 7, 2008
137. Controversies in Presbyopic IOL Surgery; ASCRS; Chicago, IL; April 7, 2008
138. Preoperative Evaluation of the Presbyopic IOL Patient; Eyeonics/Crystalens Booth; ASCRS; Chicago, IL; April 6, ‘08
139. PRK, Epi-LASIK, and LASIK Nightmares: Complications in Excimer Laser Refractive Surgery; ASCRS; Chicago, IL;
April 6, 2008
140. Intralase Users Meeting; Chicago, IL April 3, 2008
141. Trattler AIRS A PRK practice One year after Intralase; Aspen Invitational Refractive Symposium; Aspen, CO; March
11, 2008
142. Pearls for Reducing Ectasia Risk; Winter Corneal Refractive Invitational Summit; Telluride, CO; February 25 th, 2008
143. Surface Ablation 2008; Aspen Corneal Society Meeting; February 20 th, 2008
144. Risk Factors for Ectasia; Aspen Corneal Society Meeting; February 18th, 2008
145. PRK vs. LASIK vs. Epi-LASIK: Is There a difference; Royal Hawaiian Eye Meeting; January 25, 2008
146. Inflammation and Pain Control for your IOL Patients who need Laser Vision Correction; Symposium at the Royal
Hawaiian Eye; January 20, 2008
147. Optimizing results of Presbyopic IOL Surgery; American Academy of Ophthalmology; New Orleans, LA; Nov 13,
‘07
148. Medications to Maximize Surface Ablation; Part of ISRS Symposium entitled: Now That You Have the Tools, How
Do You Get the Best Results? American Academy of Ophthalmology; New Orleans, LA; Nov 12, ‘07
149. Update on Nevanac Toxicity Issues with Surface Ablation; PRK, Epi-LASIK and LASIK nightmares; Complications
in laser vision correction; American Academy of Ophthalmology; New Orleans, LA; Nov 11, ‘07
150. Surface Ablation Round Table Round-Up; Refractive Subspecialty Day; American Academy of Ophthalmology; New
Orleans, LA; Nov 9, ‘07
151. PRK Nomograms; Refractive Subspecialty Day; American Academy of Ophthalmology; New Orleans, LA; Nov 9,
‘07
152. Patient Selection for SBK vs Surface Ablation; Intralase Users Group Meeting; New Orleans, LA; November 8, 2007
153. The Case for Sub-Bowman's Keratomileusis as the Ideal Keratorefractive Procedure; OSN New York; October 13, ‘07
154. Interpretation of Topography Preoperatively; Refractive IOL Symposium; Las Vegas, NV; September 30, ‘07
26
William B. Trattler, MD
155. Preoperative Evaluation of the Presbyopic IOL Patient; SOURCE (Superior Outcomes through Refractive & Cataract
Education), Manhattan, NY, Sept 15, 2007
156. Dosing and Comparison of NSAIDS; SOURCE (Superior Outcomes through Refractive & Cataract Education),
Manhattan, NY, Sept 15, 2007
157. Laser Correction of Astigmatism vs. LRIs or Toric IOLs; SOURCE (Superior Outcomes through Refractive &
Cataract Education), Manhattan, NY, Sept 15, 2007
158. Complications Panel: What would you do (case of Suprachoridal hemorrhage during toric IOL insertiont; SOURCE
(Superior Outcomes through Refractive & Cataract Education), Manhattan, NY, Sept 15, 2007
159. Case presentation: Is 12 Seconds Enough? ASCRS Summer Refractive Congress, Carlsbad, CA, August 4, 2007
160. Case presentation: To Lift or Not to Lift? ASCRS Summer Refractive Congress, Carlsbad, CA, August 4, 2007
161. Case presentation: Irregular Astigmatism and Multifocal IOLs; ASCRS Summer Refractive Congress, Carlsbad, CA,
August 4, 2007
162. Debating Today’s Refractive Controversies: Surface Ablation vs. Thin Flap LASIK; Aspen Summer Refractive
Congress; July 29th, 2007
163. Using and Choosing NSAIDs; Corneal Health Market Guidance Program; Key Biscayne, FL June 24, 2007
164. PRK, LASEK and Epi-LASIK: Is There a Difference? Ocular Surgery News Las Vegas Symposium; June 8, 2007
165. Surface versus Lamellar Excimer Treatments; Ocular Surgery News Las Vegas Symposium; June 8, 2007
166. Risk Factors for Ectasia; Tristate Ophthalmology Congress; Las Vegas, NV; May 19, 2007
167. Optimizing Results with Surface Ablation; Tristate Ophthalmology Congress; Las Vegas, NV; May 19, 2007
168. Trattler W, Tauber S, Luchs J, Majmudar P; Randomized Masked Contralateral-Eye Comparison of Ketorolac 0.4%
Versus Nepafenac 0.1% in Patients Having PRK; American Society of Cataract & Refractive Surgery; San Diego, CA;
May 1, 2007
169. Sher N, Golben M, Bond W, Trattler W, Tauber; S; Randomized Trial of Topical Bromfenac 0.09% Versus
Ketorolac 0.4% for Control of Post-PRK Pain and Discomfort; American Society of Cataract & Refractive Surgery;
San Diego, CA; May 1, 2007
170. Medicolegal Issues in Refractive Surgery; American Society of Cataract & Refractive Surgery; San Diego, CA; April
29, 2007
171. Vision and Sports: Sports Ophthalmology Society of the Americas; American Society of Cataract & Refractive
Surgery; San Diego, CA; May 1, 2007
172. Surface Ablation (PTK, PRK, LASEK) for Complicated Post-Refractive Surgery and Post-Surgical Eyes; American
Society of Cataract & Refractive Surgery; San Diego, CA; May 1, 2007
173. Advanced Surface Ablation: Pearls for Perfecting Preop and Postop Care from Pioneers and Pundits; American
Society of Cataract & Refractive Surgery; San Diego, CA; April 29, 2007
174. Controversies in Refractive Surgery; American Society of Cataract & Refractive Surgery; San Diego, CA; April 28,
2007
175. Identifying Risk Factors for Ectasia: A practical Approach; American Society of Cataract & Refractive Surgery; San
Diego, CA; April 28, 2007
176. Update on Dry Eye; Sixth Annual Pacific Eye Insitute Annual Meeting; San Francisco, CA; March 23 rd, 2007
27
William B. Trattler, MD
177. Surface Management in PRK and LASIK; Aspen Invitational Refractive Symposium; March 5, 2007
178. Presbyopic IOLs in 2007, Aspen Cornea Society, Feb 23, 2007
179. Risk Factors for Ectasia; Aspen Corneal Society; Feb 21, 2007
180. Surface Ablation 2007; Aspen Corneal Society; Feb 19, 2007
181. Optive; Allergan Speaker’s Training, February 2, 2007
182. Optive Round Table; Allergan National Sales Meeting, Anaheim, CA; January 22, 2007
183. Risk Factors for Ectasia; Bascom Palmer’s Inter-American Course in Clinical Ophthalmology; Miami, FL; Nov
20,2006
184. Update on Surface Ablation; Bascom Palmer’s Inter-American Course; Miami, FL; Nov 20, 2006
185. Epi-LASIK Complications; New Refractive Techniques and LASIK Complications Course; The American Academy
of Ophthalmology Annual Meeting; Las Vegas, NV; November 14, 2006
186. Case Report: Two cases of Ectasia Following LASIK; PRK, EpiLASIK, LASEK, and LASIK Nightmares Course;
The American Academy of Ophthalmology Annual Meeting; Las Vegas, NV; November 13, 2006
187. Evolving Concepts of Topical Antihistamines/Mast Cell Stabilizers; Venetian Hotel, Las Vegas, NV; Nov 11, 2006
188. Pain Control in Epi-LASIK and PRK; Ocular Surgery News 2006 New York Symposium; Manhattan, NY; October
14, 2006
189. Acrysof Toric IOL,
CA, Sept 30, 2006
SOURCE (Superior Outcomes through Refractive & Cataract Education), New Port Beach,
190. Dry Eye in Cataract & Refractive Surgery, SOURCE, New Port Beach, CA; Sept 30 2006
191. Pain control with Surface Ablation, SOURCE, New Port Beach, CA; Sept 30 2006
192. Managing Postoperative Issues in Restor Patients, SOURCE, New Port Beach, CA; Sept 30 2006
193. Acrysof Aspheric IOL and Micro-Coaxial Phacoemulsification, SOURCE, New Port Beach, CA; Sept 30 2006
194. Managing Post-LASIK Dry Eye in Patients with Iatrogenic Ectasia. ASCRS Summer Refractive Congress; Boston,
August 2006
195. Case Report: Double Trouble in the Laser Suite: Report of 2 cases of Iatrogenic Ectasia on the Same Operating
Day. ASCRS Summer Refractive Congress; Boston, August 2006
196. Advanced Surface Ablation; New Horizons in Ophthalmology; Aspen, CO; July 2006
197. Risk Factors For Ectasia; New Horizons in Ophthalmology; Aspen, CO; July 2006
198. Custom Enhancements; Aspen Advanced Refractive Surgery Congress; Aspen, CO; July 2006
199. Optimizing Cataract & Refractive Surgery Outcomes; OSN Las Vegas 2006 Improving Your Odds;
June 9, 2006, Las Vegas, NV
200. Advanced Surface Ablation; OSN Las Vegas 2006 Improving Your Odds; June 9, 2006, Las Vegas, NV
201. The Role of an Artificial Tear in the Treatment of Dry Eye; Evolution in Anterior Segment Therapeutics, Tuscon, AZ;
May 21. 2006
202. Optimizing Outcomes in Refractive Surgery; Evolution in Anterior Segment Therapeutics, Tuscon, AZ; May 21. 2006
28
William B. Trattler, MD
203. Optimizing Results in Cataract & Refractive Surgery; 90th Clinical Assembly of the American Osteopathic Colleges
of Ophthalmology & Otolaryngology Foundation; May 4, 2006, Orlando, FL
204. Topical NSAIDs and Surface Ablation; 15th Anniversary VISTA Scientific Conference; April 30, 2006
205. Comparing Ophthalmic Nonsteroidal Anti-inflammatory Drugs; Evolution in Anterior Segment Therapeutics,
Aventura, FL April 1, 2006
206. The Role of an Artificial Tear in the Treatment of Dry Eye; Evolution in Anterior Segment Therapeutics, Aventura, FL
April 1, 2006
207. Risk Factors for Ectasia, The American Society of Cataract & Refractive Surgery Annual Meeting, March 20, 2006,
San Francisco, CA
208. Medical-legal Issues in Refractive Surgery, The American Society of Cataract & Refractive Surgery Annual Meeting,
March 20, 2006, San Francisco, CA
209. Pre- and Post-operative Care of Epi-LASIK Patients; at the Norwood Booth, The American Society of Cataract &
Refractive Surgery Annual Meeting, March 20, 2006, San Francisco, CA
210. Late Presentation of Diffuse Lamellar Keratitis in LASIK Patients; The American Society of Cataract & Refractive
Surgery Annual Meeting, March 19, 2006, San Francisco, CA
211. Not all Artificial Tears are the Same; at the Allergan Booth; The American Society of Cataract & Refractive Surgery
Annual Meeting, March 19, 2006, San Francisco, CA
212. Surface Ablation For Complicated Eyes, The American Society of Cataract & Refractive Surgery Annual Meeting,
March 18, 2006, San Francisco, CA
213. Delayed Healing following Nevanac in Epi-LASIK Patients; Aspen Invitational Refractive Symposium; March 2006
214. Wavefront-guided LASEK to Enhance Previous LASIK; Aspen Cornea Society; February 2006
215. Risk Factors for Ectasia; Aspen Cornea Society; February 2006
216. Update on Advanced Surface Ablation: Epi-LASIK, LASEK and PRK; Aspen Cornea Society; February 2006
217. An Update on Dry Eye & Restasis; Inspire Speakers Training, January 2006 Las Vegas
218. PRK & LASEK to Enhance Previous LASEK, Hawaiian Eye Meeting, Jan 2006, Maui, HI
219. Epi-LASIK & Advanced Surface Ablation Update; Florida Society of Ophthalmology, Dec 2005, Boca Raton, FL
220. Epi-LASIK Skills Transfer Course; October 13, 2005; Chicago, IL
221. Course Instructor, Phacoemulsification Lab for Ophthalmology Residents, The American Academy of Ophthalmology
Annual Meeting, October 2005, Chicago, IL
222. Epi-LASIK Skills Transfer Course; August 20, 2005; Boston, MA
223. Does Pupil Size matter? Cornea Society & Paton Society Federated Scientific Session; Saturday, October 15, 2005
Chicago, Illinois
224. LASEK to Enhance Previous LASIK; ASCRS Summer Refractive Congress; August 2005, Seattle, WA
225. Does Pupil Size Matter? ASCRS Summer Refractive Congress; August 2005, Seattle, WA
226. W. Trattler, B. Larson; Risk Factors For Nighttime Vision Problems After LASIK and LASEK; The Fourth
International Congress on Epi-LASIK & LASEK, and Advanced Surface Ablation; April 2005, Ft. Lauderdale, FL
29
William B. Trattler, MD
227. W. Trattler, R. Epstein, D. Hardten, B. Boxer Wachler, P. Amoils, M. Swanson, & M. Smolek; Ectasia: Risk Factors
& Treatment Options; The American Society of Cataract & Refractive Surgery Annual Meeting, April ‘05,
Washington D.C.
228. W. Trattler, J. Salz, J. Holladay, B. Boxer Wachler, & S. Brown; Blinded By The Light; The Pupil in Refractive
Surgery. The American Society of Cataract & Refractive Surgery Annual Meeting, April ‘05, Washington D.C.
229. W. Trattler, N. Sher, W. Zeller; Medicolegal Issues in Refractive Surgery; The American Society of Cataract &
Refractive Surgery Annual Meeting, April ‘05, Washington D.C.
230. W. Trattler; Surface Ablation (PTK. PRK & LASEK) For Complicated Eyes; The American Society of Cataract &
Refractive Surgery Annual Meeting, April ‘05, Washington D.C.
231. W. Trattler, B. Larson; Risk Factors For Nighttime Vision Problems After LASIK and LASEK; The American
Society of Cataract & Refractive Surgery Annual Meeting, April ‘05, Washington D.C.
232. Allergy Update: Review of Conjunctival Allergen Challenge Studies For Allergic Conjunctivitis; Inspire Speaker
Training; Jacksonville, FL Feb 26-27, 2005
233. W. Trattler, MD, B. Larson, MD; Risk Factors for Starburst Phenomena in Refractive Surgery Patients;
Aspen Corneal Society Meeting, Aspen, CO Feb 22, 2005
234. Update on Surface Ablation; Aspen Corneal Society Meeting, Aspen, CO Feb 21, 2005
235. W. Trattler, MD, B. Larson, MD: Risk Factors for Night Time Vision Phenomena; Cornea Society Meeting,
Nov. 2004; New Orleans, LA
236. Course Instructor, Phacoemulsification Lab for Ophthalmology Residents, The American Academy of Ophthalmology
Annual Meeting, November 2004, New Orleans, LA
237. Update on PRK and LASEK, Florida Society of Ophthalmology Refractive Surgery Symposium, Aug 04, Orlando, FL
238. W. Trattler, M. Smolek, D. Hardten, R. Krueger. D. Reinstein, P. Amoils, J. Hiatt, Pearls to Avoid Post-LASIK
Ectasia; The American Society of Cataract & Refractive Surgery Annual Meeting, May ‘04, San Diego, CA
239. W. Trattler, D.Azar, P Majmudar., P Amoils; Update on LASEK & Advanced Surface ablation; The American
Society of Cataract & Refractive Surgery Annual Meeting, May 2004, San Diego, CA
240. PRK/LASEK to enhance Previous LASIK; The American Society of Cataract & Refractive Surgery Annual Meeting,
May 2004, San Diego, CA
241. C. Quinn, W. Trattler, Late Presentations of Diffuse Lamellar Keratitis Following Minor Trauma; The American
Society of Cataract & Refractive Surgery Annual Meeting, May 2004, San Diego, CA
242. An Update on LASIK Complications; 88th Clinical Assembly of the American Osteopathic Colleges of Ophthalmology
& Otolaryngology Foundation; April 23, 2004, Miami, FL
243. PRK & LASEK to Enhance Previous LASEK; The 3rd International Congress on LASEK & Epi- LASEK; March
2004, Houston, TX
244. Haze and Pain Control with PRK & LASEK; The Aspen Corneal Society Meeting; Feb 2004
245. PRK & LASEK over LASIK Flaps; The Aspen Corneal Society Meeting; Feb 2004
246. W. Trattler, MD, Panel Member, LASEK Course; The American Academy of Ophthalmology Annual Meeting
November 2003, Anaheim, CA
247. Course Instructor, Phacoemulsification Lab for Ophthalmology Residents, The American Academy of Ophthalmology
Annual Meeting, November 2003, Anaheim, CA
30
William B. Trattler, MD
248. Course faculty, Medical legal Issues in Refractive Surgery, The American Society of Cataract and Refractive Surgery
Annual Meeting, April 14, 2003, San Francisco, CA
249. Course participant, LASEK Course, The American Society of Cataract and Refractive Surgery Annual Meeting, April
14 2003, San Francisco, CA
250. Surface ablation over LASIK Flaps, The American Society of Cataract and Refractive Surgery Annual Meeting, April
15, 2003, San Francisco, CA
251. Surface Ablation over LASIK Flaps, The Aspen Corneal Society Meeting; Feb. 2003
252. Course Instructor, Phacoemulsification Lab for Ophthalmology Residents, The American Academy of Ophthalmology
Annual Meeting, October 2002, Orlando, FL
253. Surface Ablation over LASIK Flaps; The Florida Society of Ophthalmology Annual Meeting; June 2002, Miami, FL
254. Course Instructor, Phacoemulsification Lab for Ophthalmology Residents, The American Academy of Ophthalmology
Annual Meeting, November 2001, New Orleans, LA
255. Internet Marketing and Website Development. The American Academy of Ophthalmology Annual Meeting,
November 2001, New Orleans, LA
256. Internet Marketing and Website Development. The American Society of Cataract and Refractive Surgery Annual
Meeting, April 2001, San Diego, CA
257. Internet Marketing and Website Development. The American Academy of Ophthalmology Annual Meeting, October
2000, Dallas, Texas
258. W. Trattler, J.W. Streilein, and S.W. Cousins, Resistance of the Anterior Chamber to Immunogenic Inflammation
(Immune Privilege) Can Be Abolished with Gamma Interferon. The Association for Research in Vision and
Ophthalmology (ARVO), Annual Spring Meeting, May 1990, Sarasota, Florida
259. W. Trattler, J.W. Streilein, and S.W. Cousins, The Anterior Chamber of the Mouse Eye is Resistant to Delayed
Type Hypersensitivity Unless Immune Privilege is Abrogated by IFN-gamma. The 1990 Eastern Student
Research Forum, February 1990, Miami, Florida
Moderator/Panelist/Judge Positions
1. Moderator: Southeast Cornea Society Meeting; Kiawah Eye; Kiawah, South Carolina; June 4, 2011
2. Moderator: KERATOREFRACTIVE: Topography, Tomography, Thermokeratoplasty; American Society Of
Cataract & Refractive Surgery Annual Meeting; March 29, 2011; San Diego, CA
3. Moderator :
Cataract and Refractive Surgery Shop Talk; 2010 Advanced Refractive Symposium in Deer Valley,
Utah; Feb 23rd, 2010
4. Panelist:
Panel Discussion: Preoperative Evaluation of the Presbyopic IOL Patient; Refractive IOL Symposium ;
Las Vegas, NV; Sept 28, 2008
5. Panelist:
Panel Discussion:My Most Difficult Refractive IOL Case; Refractive IOL symposium ; Las Vegas, NV;
Sept 28, 2008
6. Panelist:
Presentations & Panel Discussion: What Treatment Would You Do? Refractive IOL symposium ; Las
Vegas, NV; Sept 28, 2008
7. Moderator:
Symposium on Laser Refractive Surgery; 13TH ANNUAL JOINT MEETING OF OSN, SOI &
AICCER; May 10, 2008; Naples, Italy
31
William B. Trattler, MD
8. Moderator:
Superior Outcomes through Refractive and Cataract Education (SOURCE); Symposium; The Seventh
International Congress on Surface Ablation and Sub Bowman's Keratomileusis; Ft. Lauderdale, FL,
April 26, 2008
9. Moderator:
KERATOREFRACTIVE LASIK: Presbyopia and Flaps; American Society Of Cataract & Refractive
Surgery Annual Meeting; April 6th, 2008; Chicago, IL
10. Panelist:
Refractive Surgery Free Paper Session; American Academy of Ophthalmology; New Orleans,
LA; Nov 13, ‘07
11. Panelist:
Presentations & Panel Discussion; My Most Difficult Refractive IOL; Refractive IOL Symposium; Las
Vegas, NV; September 30, 2007
12. Panelist:
Presentations & Panel Discussion: What Treatment Would You Do? Refractive IOL Symposium; Las
Vegas, NV; Sept 30, 2007
13. Panelist:
Panel and Attendee Discussion: Little Tricks and Pearls that Work; Refractive IOL Symposium; Las
Vegas, NV; September 29, 2007
14. Moderator:
Debating Today’s Refractive Controversies; Aspen Summer Refractive Congress; July 29, 2007
15. Panelist:
Controversies in Ocular Infection, Inflammation, Allergy, and Dry Eye, OSN Las Vegas, June 8, 2007
16. Moderator:
Accommodating Intraocular Lenses; The American Society of Cataract & Refractive Surgery Annual
Meeting, April 29, 2007; San Diego, CA.
17. Poster Judge: The American Society of Cataract & Refractive Surgery Annual Meeting, April 27, ‘07, San Diego, CA
18. Panelist:
Refractive IOL Symposium; December 3, 2006; Scottsdale, AZ
19. Moderator:
Joint Meeting Refractive Free Paper Session, The American Academy of Ophthalmology Annual
Meeting, November 13, 2006; Las Vegas, NV
20. Panelist:
Corneal Health Roundtable: NSAIDS and Anti-Infectives; Ocular Surgery News 2006 New York
Symposium; Manhattan, NY; October 15, 2006
21. Poster Judge: The American Society of Cataract & Refractive Surgery Annual Meeting, March 17, ‘06, San Fran, CA
22. Moderator:
Dry Eye Symposium, Florida Society of Ophthalmology, December 2005
23. Moderator:
Epi-LASIK Outcomes, Indications, Complications; The Fourth International Congress on Epi-LASIK &
LASEK, and Advanced Surface Ablation; April 2005, Ft. Lauderdale, FL
24. Moderator:
Refractive Surface Ablation Session; The American Society of Cataract & Refractive Surgery Annual
Meeting, April 17, 20005, Washington D.C.
25. Panelist:
Mechanical and Femtosecond Microkeratomes Session; The American Society of Cataract & Refractive
Surgery Annual Meeting, April ‘05, Washington D.C.
26. Poster Judge: The American Society of Cataract & Refractive Surgery Annual Meeting, April 16,‘05, Washington D.C.
27. Panelist:
Surface Ablation Session; The American Society of Cataract & Refractive Surgery Annual Meeting,
May ‘04, San Diego, CA
LECTURES TO LOCAL OPHTHALMOLOGY/MEDICAL GROUPS
12/8/2009:
11/10/2009
Inspire Clinical Council Meeting; Miami, FL
Presbyopic IOLs (sponsored by Review of Ophthalmology/AMO): Beverley Hills, CA
32
William B. Trattler, MD
03/16/2009
2/9/2009:
11/8/2008:
9/25/08:
6/26/08:
Azasite; Ft. Lauderdale, FL
Azasite; Miami, FL
Azasite; Atlanta, GA
Preoperative Evaluation of the Cataract Surgery Patient; Ft Lauderdale, FL
Update on Meibomain Gland Dysfunction; Atlanta; GA
6/11/2008:
Restasis Round Table: Dallas, TX
6/3/2008:
New Treatments Options for Blepharitis and Meibomian Gland Dysfunction; Miami. FL
5/21/08:
Restasis Roundtable; Houston, TX
4/2/2008:
Optimizing Results with Cataract & Refractive Surgery; Chicago, IL
2/6/2008:
Optimizing results with Cataract & Refractive Surgery; Houston, TX
11/10/07
Azasite & Topography Lecture; New Orleans, LA
10/4/07
Azasite & Topography Lecture; Dallas, Tx
8/30/07
Restasis Smart Start; Tampa, FL
8/23/07
Restasis Smart Start; Atlanta, GA
8/09/07
Restasis Smart Start; Dallas, TX
6/21/07
Optimizing Results with Cataract and Refractive Surgery; Santa Barbara, CA
3/22/07
Optimizing Results in Cataract and Refractive Surgery; San Francisco, CA
11/28/06
Update on Research in cataract and refractive surgery, Miami, FL
6/22/06
Optimizing Cataract and Refractive Surgery Results; Jacksonville, FL
6/10/06
Update on Ocular Allergy & Dry Eye; Las Vegas, NV
4/11/06
Optimizing Cataract and Refractive Surgery Results; Ft. Lauderdale, FL
3/29/06
Optimizing Cataract and Refractive Surgery Results; West Palm Beach, FL
2/10/06
Dry Eye and Ocular Allergy: Coral Springs, FL
1/10/06
Dry Eye & Refractive Surgery; Miami, FL
9/15/05
Update on Dry Eye & Ocular Allergy; Tampa, FL
7/19/05
Understanding Dry Eye & Its Impact on Ocular Allergy; Cedars Sinai Ophthalmology Department
Meeting; Los Angeles, CA
7/19/05
Update on Dry Eye & Ocular Allergy; Glendale Eye Center Quarterly Lecture Series, Los Angeles, CA
6/29/05
Understanding Dry Eye and Its Impact on Ocular Allergy; Northwest Allergy Group; Seattle, WA
5/9/05
Controversies in Endophthalmitis Prophylaxis; Miami, FL
4/1/05
Update on Dry Eye and Ocular Allergy; Allergy Journal Club; Boca Raton, FL
6/21/04
Refractive Surgery Complications; Update on Ocular Allergy, Ft. Lauderdale, FL
5/20/04
Refractive Surgery Complications; Update on Ocular Allergy;
West Palm Beach Ophthalmology Society; West Palm Beach, FL
4/22/04
Dry Eye Following Post-LASIK Ectasia; Update on Ocular Allergy; Atlanta, GA
5/22/03
Update on the Treatment of Dry Eye; Greenville, SC
5/15/03
Strategies for the Care of Dry Eye Patients; Coconut Grove, FL
5/01/03
Refractive Surgery Complications; Ocular Allergy Update
Augusta Ophthalmology Society, Augusta, GA
3/29/03
Allergic Eye Disease: Meeting the Challenge of the Season; Dallas, Tx
3/21/03
Update on Surface ablation; Treatment Options for Ocular Allergy; Jupiter, FL
4/25/02
Pearls for performing LASEK; Infections following LASIK; Ocular Allergy; Cary, NC
4/18/02
Pearls for performing LASEK; Infections following LASIK; Ocular Allergy; Chatanooga, TN
4/17/02
Pearls for performing LASEK; Infections following LASIK; Ocular Allergy; Miami, FL
4/03/02
Identification and Treatment of Infections following LASIK; Understanding the Mechanisms and
33
William B. Trattler, MD
Treatment of the Early and Late Phases of Ocular Allergy; Charleston, S.C.
3/21/02
Understanding the Mechanisms & Treatment of the Early and Late Phases of Ocular Allergy; Jupiter, FL
3/14/02
Understanding the Mechanisms & Treatment of the Early and Late Phases of Ocular Allergy;Orlando, FL
1/21/02
Surgical Pearls for the use of Healon 5 and the Pharmacia 911A Silicone lens; Ft. Lauderdale, FL
8/23/01
Patient Selection for Refractive Surgery: Identifying pts who are poor candidates for LASIK, Atlanta,GA
Webinar
Webinar Course Director: Steroid Innovations and Treatment Education (sponsored by Sirion)
Multiple dates in Jan, February and March 2009
Faculty: Carlos Buznego, MD; Parag Majmudar, MD; Steven Silverstein, MD
Website: SiteCME.org
REVIEWER:
2005: Ophthalmic Medical Assisting, Fourth Edition; An Independent Study Course; American Academy of
Ophthalmology; 2006
PEER-REVIEW
2013 to Present: Ophthalmology
2006 to Present: Journal of Cataract & Refractive Surgery
2006 to Present Cornea
2007 to Present American Journal of Ophthalmology
2008 to Present Ophthalmic Research
EDITORIAL BOARDS
2010 to 2013:
Editorial Board of Premier Surgeon
2008 to present:
Cataract and Refractive Surgery Today
2009 to present:
Ocular Surgery News: OSN SuperSite Section of the editorial board
2009 to present:
Refractive EyeCare Editorial Board
2012 to present:
World Journal of Ophthalmology (WJO)
2008 to 2013:
EyeNet (Magazine of the American Academy of Ophthalmology)
2009
International Ophthalmology Clinics: Associate Editor
PROFESSIONAL ASSOCIATIONS
2010-present: American-European Congress of Ophthalmic Surgery (AECOS): Founding Board Member
1996 to present: Member, American Academy of Ophthalmology (AAO)
2013 to present: Annual Meeting Program Committee - Refractive Surgery - Member Subcommittee
2007 to 2010 Chairperson, Refractive Management/Intervention Panel, COMPASS
Develop online Refractive Management content for an comprehensive online educational tool
2006 to 2010: Member: Ophthalmic Technology Assessment Committee (OTAC) Refractive Surgery Panel;
2009 to present: Annual Meeting Program Committee –
Refractive Surgery - Reviewer for Annual Meeting Program
2003 to 2007: Member of the Ophthalmic Knowledge Base panel for Refractive Management/Intervention
34
William B. Trattler, MD
2007 to present: Member: International Society of Refractive Surgery:
2011: Appointed to ISRS Executive Board
2010: appointed as an ISRS International Council Member Representative for the United States
2010: appointed to ISRS Program Committee – Member
2013: ISRS - Multimedia Library Editorial Board - Member
1997: Member, American Society of Cataract and Refractive Surgery (ASCRS)
2009 to present: Member: ASCRS Refractive Surgery Clinical Committee
2000 to present: Member, Florida Society of Ophthalmology
1997 to present: Miami Ophthalmology Society
2006: President
2005: Treasurer
2004: Secretary:
2007 to present: Member with Thesis, The Cornea Society
2011to present: CEDARS (Cornea, Externdal Dissease, and Refractive Surgeons): Founding Member
Advertising/Nominating Groups for “Top Doctors”
2008-2012:
Florida Super Doctor – South Florida: Top 5% of South Florida Doctors, as selected by peernominations as well as a panel review process and independent research on candidates
2008-2013
Castle Connolly Top Doctor
2009-2014:
Elected to the Best Doctors in America: http://www.bestdoctors.com
2010:
Patient Choice Award:
Consulting/Advisory Boards
Omega Ophthalmics:
2014
Auven Therapeutics
2014
Sucampo
2014
Baush and Lomb
2010 to present
CXLUSA:
2010 to present
35
William B. Trattler, MD
LaserACE:
2011 to 2013
Allergan:
2007 to present
Abbott Medical Optics:
2009 to present
Alcon:
2010 to present
LensAR:
2010 to present
QLTI
2010 to 2011
ISTA:
2010 to 2012
Fera Pharmaceuticas:
2010 to 2011
Tear Science
2010 to present
Tear Lab:
2013 to present
EyeGate:
2011 to 2012
Foresight Biotherapeutics: 2009 to 2013
Agile Sciences:
2010 to 2011
Inspire Pharmaceuticals:
2005 to 2011
Aton Pharmaceuticals:
2008 to 2010
Lectures Provided at Consultants Meeting
4/9/11
Allergan Dry Eye Advisory Summitt; Phoenix, AZ
9/24/2010:
Ista Pharmaceuticals Medical Advisory Board Meeting; Orange County, CA
Cataract and Dry Eye: Prospective Health Assessment of Cataract Patients Ocular Surface Study
Bromday WorkShop Leader
Surgery Center Affiliations:
Medical Arts Surgery Center:
Miami, FL
Surgical Park:
Miami, FL
Volunteer Work
Good News Care Center, Miami, FL:
2002 to present
The Good News Care Center Our provides free medical services to uninsured persons who are low income regardless of
race, occupation, national origin or immigrant’s status.
My role has been to provide ophthalmology exams and surgery on a volunteer basis to patients who are part of the Good
News Care Center. Between 50 and 100 patient exams are performed at my office each year, and 5 to 10 surgeries (cataract,
ptyergium and corneal transplants) are provided to patients each years.
36